id	sid	tid	token	lemma	pos
gs-4428	1	1	georgian	georgian	PROPN
gs-4428	1	2	scientists/	scientists/	NUM
gs-4428	1	3	.	.	PUNCT
gs-4428	2	1	7	7	NUM
gs-4428	2	2	n	n	DET
gs-4428	2	3	4	4	NUM
gs-4428	2	4	,	,	PUNCT
gs-4428	2	5	2025	2025	NUM
gs-4428	2	6	621	621	NUM
gs-4428	2	7	georgian	georgian	ADJ
gs-4428	2	8	scientists	scientist	NOUN
gs-4428	2	9	vol	vol	NOUN
gs-4428	2	10	.	.	PUNCT
gs-4428	2	11	7	7	NUM
gs-4428	2	12	issue	issue	NOUN
gs-4428	2	13	4	4	NUM
gs-4428	2	14	,	,	PUNCT
gs-4428	2	15	2025	2025	NUM
gs-4428	2	16	https://doi.org/10.52340/gs.2025.07.04.43	https://doi.org/10.52340/gs.2025.07.04.43	NUM
gs-4428	2	17	hepatitis	hepatitis	PROPN
gs-4428	2	18	b	b	PROPN
gs-4428	2	19	in	in	ADP
gs-4428	2	20	georgia	georgia	PROPN
gs-4428	2	21	:	:	PUNCT
gs-4428	2	22	progress	progress	NOUN
gs-4428	2	23	,	,	PUNCT
gs-4428	2	24	gaps	gap	NOUN
gs-4428	2	25	,	,	PUNCT
gs-4428	2	26	and	and	CCONJ
gs-4428	2	27	equity	equity	NOUN
gs-4428	2	28	across	across	ADP
gs-4428	2	29	the	the	DET
gs-4428	2	30	prevention	prevention	NOUN
gs-4428	2	31	-	-	PUNCT
gs-4428	2	32	tocare	tocare	NOUN
gs-4428	2	33	cascade	cascade	NOUN
gs-4428	2	34	lela	lela	PROPN
gs-4428	2	35	inaishvili1	inaishvili1	NOUN
gs-4428	2	36	tamriko	tamriko	PROPN
gs-4428	2	37	bulia1	bulia1	PROPN
gs-4428	2	38	lali	lali	PROPN
gs-4428	2	39	sharvadze1	sharvadze1	PROPN
gs-4428	2	40	nikoloz	nikoloz	PROPN
gs-4428	2	41	pruidze1	pruidze1	PROPN
gs-4428	2	42	1	1	NUM
gs-4428	2	43	school	school	NOUN
gs-4428	2	44	of	of	ADP
gs-4428	2	45	health	health	NOUN
gs-4428	2	46	sciences	sciences	PROPN
gs-4428	2	47	,	,	PUNCT
gs-4428	2	48	the	the	DET
gs-4428	2	49	university	university	NOUN
gs-4428	2	50	of	of	ADP
gs-4428	2	51	georgia	georgia	PROPN
gs-4428	2	52	,	,	PUNCT
gs-4428	2	53	77a	77a	NOUN
gs-4428	2	54	kostava	kostava	PROPN
gs-4428	2	55	str	str	PROPN
gs-4428	2	56	.	.	PUNCT
gs-4428	2	57	,	,	PUNCT
gs-4428	2	58	0171	0171	NUM
gs-4428	3	1	tbilisi	tbilisi	PROPN
gs-4428	3	2	,	,	PUNCT
gs-4428	3	3	georgia	georgia	PROPN
gs-4428	3	4	abstract	abstract	ADJ
gs-4428	3	5	aim	aim	NOUN
gs-4428	3	6	:	:	PUNCT
gs-4428	4	1	hepatitis	hepatitis	PROPN
gs-4428	4	2	b	b	PROPN
gs-4428	4	3	virus	virus	NOUN
gs-4428	4	4	(	(	PUNCT
gs-4428	4	5	hbv	hbv	NOUN
gs-4428	4	6	)	)	PUNCT
gs-4428	4	7	remains	remain	VERB
gs-4428	4	8	a	a	DET
gs-4428	4	9	major	major	ADJ
gs-4428	4	10	cause	cause	NOUN
gs-4428	4	11	of	of	ADP
gs-4428	4	12	cirrhosis	cirrhosis	NOUN
gs-4428	4	13	and	and	CCONJ
gs-4428	4	14	hepatocellular	hepatocellular	ADJ
gs-4428	4	15	carcinoma	carcinoma	NOUN
gs-4428	4	16	globally	globally	ADV
gs-4428	4	17	.	.	PUNCT
gs-4428	5	1	this	this	DET
gs-4428	5	2	review	review	NOUN
gs-4428	5	3	assesses	assess	VERB
gs-4428	5	4	georgia	georgia	PROPN
gs-4428	5	5	’s	’s	PART
gs-4428	5	6	progress	progress	NOUN
gs-4428	5	7	toward	toward	ADP
gs-4428	5	8	the	the	DET
gs-4428	5	9	world	world	NOUN
gs-4428	5	10	health	health	NOUN
gs-4428	5	11	organization	organization	NOUN
gs-4428	5	12	(	(	PUNCT
gs-4428	5	13	who	who	PRON
gs-4428	5	14	)	)	PUNCT
gs-4428	5	15	global	global	ADJ
gs-4428	5	16	health	health	NOUN
gs-4428	5	17	sector	sector	NOUN
gs-4428	5	18	strategies	strategy	NOUN
gs-4428	5	19	(	(	PUNCT
gs-4428	5	20	ghss	ghss	PROPN
gs-4428	5	21	)	)	PUNCT
gs-4428	5	22	2022–2030	2022–2030	NUM
gs-4428	5	23	targets	target	NOUN
gs-4428	5	24	for	for	ADP
gs-4428	5	25	eliminating	eliminate	VERB
gs-4428	5	26	viral	viral	ADJ
gs-4428	5	27	hepatitis	hepatitis	NOUN
gs-4428	5	28	as	as	ADP
gs-4428	5	29	a	a	DET
gs-4428	5	30	public	public	ADJ
gs-4428	5	31	-	-	PUNCT
gs-4428	5	32	health	health	NOUN
gs-4428	5	33	problem	problem	NOUN
gs-4428	5	34	,	,	PUNCT
gs-4428	5	35	with	with	ADP
gs-4428	5	36	a	a	DET
gs-4428	5	37	focus	focus	NOUN
gs-4428	5	38	on	on	ADP
gs-4428	5	39	the	the	DET
gs-4428	5	40	prevention	prevention	NOUN
gs-4428	5	41	-	-	PUNCT
gs-4428	5	42	tocare	tocare	NOUN
gs-4428	5	43	cascade	cascade	NOUN
gs-4428	5	44	.	.	PUNCT
gs-4428	6	1	subject	subject	NOUN
gs-4428	6	2	and	and	CCONJ
gs-4428	6	3	methods	method	NOUN
gs-4428	6	4	:	:	PUNCT
gs-4428	7	1	georgia	georgia	PROPN
gs-4428	7	2	,	,	PUNCT
gs-4428	7	3	a	a	DET
gs-4428	7	4	country	country	NOUN
gs-4428	7	5	in	in	ADP
gs-4428	7	6	the	the	DET
gs-4428	7	7	who	who	PRON
gs-4428	7	8	european	european	PROPN
gs-4428	7	9	region	region	NOUN
gs-4428	7	10	,	,	PUNCT
gs-4428	7	11	has	have	AUX
gs-4428	7	12	sustained	sustain	VERB
gs-4428	7	13	high	high	ADJ
gs-4428	7	14	infant	infant	NOUN
gs-4428	7	15	hepatitis	hepatitis	PROPN
gs-4428	7	16	b	b	PROPN
gs-4428	7	17	vaccination	vaccination	NOUN
gs-4428	7	18	coverage	coverage	NOUN
gs-4428	7	19	and	and	CCONJ
gs-4428	7	20	conducted	conduct	VERB
gs-4428	7	21	two	two	NUM
gs-4428	7	22	nationwide	nationwide	ADJ
gs-4428	7	23	hepatitis	hepatitis	PROPN
gs-4428	7	24	b	b	PROPN
gs-4428	7	25	virus	virus	PROPN
gs-4428	7	26	serosurveys	serosurvey	NOUN
gs-4428	7	27	,	,	PUNCT
gs-4428	7	28	yet	yet	ADV
gs-4428	7	29	publicly	publicly	ADV
gs-4428	7	30	available	available	ADJ
gs-4428	7	31	evidence	evidence	NOUN
gs-4428	7	32	is	be	AUX
gs-4428	7	33	dispersed	disperse	VERB
gs-4428	7	34	.	.	PUNCT
gs-4428	8	1	we	we	PRON
gs-4428	8	2	systematically	systematically	ADV
gs-4428	8	3	searched	search	VERB
gs-4428	8	4	medline	medline	NOUN
gs-4428	8	5	,	,	PUNCT
gs-4428	8	6	embase	embase	NOUN
gs-4428	8	7	and	and	CCONJ
gs-4428	8	8	scopus	scopus	NOUN
gs-4428	8	9	,	,	PUNCT
gs-4428	8	10	and	and	CCONJ
gs-4428	8	11	reviewed	review	VERB
gs-4428	8	12	grey	grey	PROPN
gs-4428	8	13	literature	literature	NOUN
gs-4428	8	14	from	from	ADP
gs-4428	8	15	who	who	PRON
gs-4428	8	16	,	,	PUNCT
gs-4428	8	17	who	who	PRON
gs-4428	8	18	/	/	SYM
gs-4428	8	19	unicef	unicef	NOUN
gs-4428	8	20	estimates	estimate	NOUN
gs-4428	8	21	of	of	ADP
gs-4428	8	22	national	national	ADJ
gs-4428	8	23	immunization	immunization	NOUN
gs-4428	8	24	coverage	coverage	NOUN
gs-4428	8	25	(	(	PUNCT
gs-4428	8	26	wuenic	wuenic	NOUN
gs-4428	8	27	)	)	PUNCT
gs-4428	8	28	,	,	PUNCT
gs-4428	8	29	the	the	DET
gs-4428	8	30	u.s	u.s	PROPN
gs-4428	8	31	.	.	PROPN
gs-4428	8	32	centers	center	NOUN
gs-4428	8	33	for	for	ADP
gs-4428	8	34	disease	disease	NOUN
gs-4428	8	35	control	control	NOUN
gs-4428	8	36	and	and	CCONJ
gs-4428	8	37	prevention	prevention	NOUN
gs-4428	8	38	(	(	PUNCT
gs-4428	8	39	cdc	cdc	PROPN
gs-4428	8	40	)	)	PUNCT
gs-4428	8	41	,	,	PUNCT
gs-4428	8	42	the	the	DET
gs-4428	8	43	coalition	coalition	NOUN
gs-4428	8	44	for	for	ADP
gs-4428	8	45	global	global	ADJ
gs-4428	8	46	hepatitis	hepatitis	NOUN
gs-4428	8	47	elimination	elimination	NOUN
gs-4428	8	48	(	(	PUNCT
gs-4428	8	49	cghe	cghe	ADJ
gs-4428	8	50	)	)	PUNCT
gs-4428	8	51	and	and	CCONJ
gs-4428	8	52	national	national	ADJ
gs-4428	8	53	/	/	SYM
gs-4428	8	54	partner	partner	NOUN
gs-4428	8	55	reports	report	NOUN
gs-4428	8	56	.	.	PUNCT
gs-4428	9	1	evidence	evidence	NOUN
gs-4428	9	2	was	be	AUX
gs-4428	9	3	synthesized	synthesize	VERB
gs-4428	9	4	across	across	ADP
gs-4428	9	5	four	four	NUM
gs-4428	9	6	domains	domain	NOUN
gs-4428	9	7	:	:	PUNCT
gs-4428	9	8	epidemiology	epidemiology	NOUN
gs-4428	9	9	;	;	PUNCT
gs-4428	9	10	prevention	prevention	NOUN
gs-4428	9	11	through	through	ADP
gs-4428	9	12	vaccination	vaccination	NOUN
gs-4428	9	13	and	and	CCONJ
gs-4428	9	14	prevention	prevention	NOUN
gs-4428	9	15	of	of	ADP
gs-4428	9	16	mother	mother	NOUN
gs-4428	9	17	-	-	PUNCT
gs-4428	9	18	to	to	ADP
gs-4428	9	19	-	-	PUNCT
gs-4428	9	20	child	child	NOUN
gs-4428	9	21	transmission	transmission	NOUN
gs-4428	9	22	;	;	PUNCT
gs-4428	9	23	testing	testing	NOUN
gs-4428	9	24	–	–	PUNCT
gs-4428	9	25	treatment	treatment	NOUN
gs-4428	9	26	care	care	NOUN
gs-4428	9	27	cascade	cascade	NOUN
gs-4428	9	28	;	;	PUNCT
gs-4428	9	29	and	and	CCONJ
gs-4428	9	30	equity	equity	NOUN
gs-4428	9	31	.	.	PUNCT
gs-4428	10	1	results	result	NOUN
gs-4428	10	2	:	:	PUNCT
gs-4428	10	3	available	available	ADJ
gs-4428	10	4	data	datum	NOUN
gs-4428	10	5	indicate	indicate	VERB
gs-4428	10	6	adult	adult	NOUN
gs-4428	10	7	hepatitis	hepatitis	NOUN
gs-4428	10	8	b	b	PROPN
gs-4428	10	9	surface	surface	NOUN
gs-4428	10	10	antigen	antigen	NOUN
gs-4428	10	11	(	(	PUNCT
gs-4428	10	12	hbsag	hbsag	NOUN
gs-4428	10	13	)	)	PUNCT
gs-4428	10	14	prevalence	prevalence	NOUN
gs-4428	10	15	of	of	ADP
gs-4428	10	16	2.9	2.9	NUM
gs-4428	10	17	%	%	NOUN
gs-4428	10	18	in	in	ADP
gs-4428	10	19	2015	2015	NUM
gs-4428	10	20	and	and	CCONJ
gs-4428	10	21	2.7	2.7	NUM
gs-4428	10	22	%	%	NOUN
gs-4428	10	23	in	in	ADP
gs-4428	10	24	2021	2021	NUM
gs-4428	10	25	;	;	PUNCT
gs-4428	10	26	among	among	ADP
gs-4428	10	27	children	child	NOUN
gs-4428	10	28	aged	age	VERB
gs-4428	10	29	5–17	5–17	NOUN
gs-4428	10	30	years	year	NOUN
gs-4428	10	31	,	,	PUNCT
gs-4428	10	32	hbsag	hbsag	ADJ
gs-4428	10	33	prevalence	prevalence	NOUN
gs-4428	10	34	was	be	AUX
gs-4428	10	35	0.03	0.03	NUM
gs-4428	10	36	%	%	NOUN
gs-4428	10	37	in	in	ADP
gs-4428	10	38	2021	2021	NUM
gs-4428	10	39	,	,	PUNCT
gs-4428	10	40	reflecting	reflect	VERB
gs-4428	10	41	immunization	immunization	NOUN
gs-4428	10	42	impact	impact	NOUN
gs-4428	10	43	.	.	PUNCT
gs-4428	11	1	hepatitis	hepatitis	PROPN
gs-4428	11	2	b	b	PROPN
gs-4428	11	3	birth	birth	NOUN
gs-4428	11	4	dose	dose	NOUN
gs-4428	11	5	and	and	CCONJ
gs-4428	11	6	three	three	NUM
gs-4428	11	7	-	-	PUNCT
gs-4428	11	8	dose	dose	VERB
gs-4428	11	9	infant	infant	PROPN
gs-4428	11	10	series	series	NOUN
gs-4428	11	11	coverage	coverage	NOUN
gs-4428	11	12	generally	generally	ADV
gs-4428	11	13	exceeded	exceed	VERB
gs-4428	11	14	90	90	NUM
gs-4428	11	15	%	%	NOUN
gs-4428	11	16	over	over	ADP
gs-4428	11	17	the	the	DET
gs-4428	11	18	last	last	ADJ
gs-4428	11	19	decade	decade	NOUN
gs-4428	11	20	.	.	PUNCT
gs-4428	12	1	however	however	ADV
gs-4428	12	2	,	,	PUNCT
gs-4428	12	3	evidence	evidence	NOUN
gs-4428	12	4	on	on	ADP
gs-4428	12	5	adult	adult	NOUN
gs-4428	12	6	diagnosis	diagnosis	NOUN
gs-4428	12	7	and	and	CCONJ
gs-4428	12	8	antiviral	antiviral	ADJ
gs-4428	12	9	treatment	treatment	NOUN
gs-4428	12	10	coverage	coverage	NOUN
gs-4428	12	11	,	,	PUNCT
gs-4428	12	12	and	and	CCONJ
gs-4428	12	13	on	on	ADP
gs-4428	12	14	subgroup	subgroup	NOUN
gs-4428	12	15	disparities	disparity	NOUN
gs-4428	12	16	,	,	PUNCT
gs-4428	12	17	remains	remain	VERB
gs-4428	12	18	limited	limited	ADJ
gs-4428	12	19	.	.	PUNCT
gs-4428	13	1	conclusion	conclusion	NOUN
gs-4428	13	2	:	:	PUNCT
gs-4428	13	3	consolidating	consolidate	VERB
gs-4428	13	4	epidemiologic	epidemiologic	ADJ
gs-4428	13	5	and	and	CCONJ
gs-4428	13	6	program	program	NOUN
gs-4428	13	7	indicators	indicator	NOUN
gs-4428	13	8	clarifies	clarify	VERB
gs-4428	13	9	georgia	georgia	PROPN
gs-4428	13	10	’s	’s	PART
gs-4428	13	11	progress	progress	NOUN
gs-4428	13	12	toward	toward	ADP
gs-4428	13	13	ghss	ghss	PROPN
gs-4428	13	14	2030	2030	NUM
gs-4428	13	15	targets	target	NOUN
gs-4428	13	16	and	and	CCONJ
gs-4428	13	17	highlights	highlight	NOUN
gs-4428	13	18	priorities	priority	NOUN
gs-4428	13	19	to	to	PART
gs-4428	13	20	strengthen	strengthen	VERB
gs-4428	13	21	adult	adult	NOUN
gs-4428	13	22	testing	testing	NOUN
gs-4428	13	23	,	,	PUNCT
gs-4428	13	24	linkage	linkage	NOUN
gs-4428	13	25	and	and	CCONJ
gs-4428	13	26	treatment	treatment	NOUN
gs-4428	13	27	,	,	PUNCT
gs-4428	13	28	and	and	CCONJ
gs-4428	13	29	to	to	PART
gs-4428	13	30	ensure	ensure	VERB
gs-4428	13	31	equitable	equitable	ADJ
gs-4428	13	32	access	access	NOUN
gs-4428	13	33	to	to	ADP
gs-4428	13	34	prevention	prevention	NOUN
gs-4428	13	35	and	and	CCONJ
gs-4428	13	36	care	care	VERB
gs-4428	13	37	across	across	ADP
gs-4428	13	38	the	the	DET
gs-4428	13	39	hepatitis	hepatitis	NOUN
gs-4428	13	40	b	b	NOUN
gs-4428	13	41	cascade	cascade	NOUN
gs-4428	13	42	.	.	PUNCT
gs-4428	14	1	keywords	keyword	NOUN
gs-4428	14	2	:	:	PUNCT
gs-4428	14	3	hepatitis	hepatitis	PROPN
gs-4428	14	4	b	b	PROPN
gs-4428	14	5	;	;	PUNCT
gs-4428	14	6	georgia	georgia	NOUN
gs-4428	14	7	;	;	PUNCT
gs-4428	14	8	vaccination	vaccination	NOUN
gs-4428	14	9	;	;	PUNCT
gs-4428	14	10	care	care	NOUN
gs-4428	14	11	cascade	cascade	NOUN
gs-4428	14	12	;	;	PUNCT
gs-4428	14	13	health	health	NOUN
gs-4428	14	14	equity	equity	NOUN
gs-4428	14	15	georgian	georgian	NOUN
gs-4428	14	16	scientists/	scientists/	NUM
gs-4428	14	17	.	.	PUNCT
gs-4428	15	1	7	7	NUM
gs-4428	15	2	n	n	DET
gs-4428	15	3	4	4	NUM
gs-4428	15	4	,	,	PUNCT
gs-4428	15	5	2025	2025	NUM
gs-4428	15	6	622	622	NUM
gs-4428	15	7	introduction	introduction	NOUN
gs-4428	15	8	viral	viral	ADJ
gs-4428	15	9	hepatitis	hepatitis	NOUN
gs-4428	15	10	remains	remain	VERB
gs-4428	15	11	one	one	NUM
gs-4428	15	12	of	of	ADP
gs-4428	15	13	the	the	DET
gs-4428	15	14	leading	lead	VERB
gs-4428	15	15	causes	cause	NOUN
gs-4428	15	16	of	of	ADP
gs-4428	15	17	chronic	chronic	ADJ
gs-4428	15	18	liver	liver	NOUN
gs-4428	15	19	disease	disease	NOUN
gs-4428	15	20	and	and	CCONJ
gs-4428	15	21	liver	liver	NOUN
gs-4428	15	22	-	-	PUNCT
gs-4428	15	23	related	relate	VERB
gs-4428	15	24	mortality	mortality	NOUN
gs-4428	15	25	worldwide	worldwide	ADV
gs-4428	15	26	.	.	PUNCT
gs-4428	16	1	in	in	ADP
gs-4428	16	2	2022	2022	NUM
gs-4428	16	3	,	,	PUNCT
gs-4428	16	4	the	the	DET
gs-4428	16	5	world	world	PROPN
gs-4428	16	6	health	health	NOUN
gs-4428	16	7	organization	organization	NOUN
gs-4428	16	8	(	(	PUNCT
gs-4428	16	9	who	who	PRON
gs-4428	16	10	)	)	PUNCT
gs-4428	16	11	adopted	adopt	VERB
gs-4428	16	12	updated	update	VERB
gs-4428	16	13	global	global	ADJ
gs-4428	16	14	health	health	NOUN
gs-4428	16	15	sector	sector	NOUN
gs-4428	16	16	strategies	strategy	NOUN
gs-4428	16	17	(	(	PUNCT
gs-4428	16	18	ghss	ghss	PROPN
gs-4428	16	19	)	)	PUNCT
gs-4428	16	20	2022–2030	2022–2030	NUM
gs-4428	16	21	,	,	PUNCT
gs-4428	16	22	which	which	PRON
gs-4428	16	23	aim	aim	VERB
gs-4428	16	24	to	to	PART
gs-4428	16	25	eliminate	eliminate	VERB
gs-4428	16	26	viral	viral	ADJ
gs-4428	16	27	hepatitis	hepatitis	NOUN
gs-4428	16	28	as	as	ADP
gs-4428	16	29	a	a	DET
gs-4428	16	30	public	public	ADJ
gs-4428	16	31	-	-	PUNCT
gs-4428	16	32	health	health	NOUN
gs-4428	16	33	problem	problem	NOUN
gs-4428	16	34	by	by	ADP
gs-4428	16	35	2030	2030	NUM
gs-4428	16	36	.	.	PUNCT
gs-4428	17	1	the	the	DET
gs-4428	17	2	targets	target	NOUN
gs-4428	17	3	call	call	VERB
gs-4428	17	4	for	for	ADP
gs-4428	17	5	a	a	DET
gs-4428	17	6	90	90	NUM
gs-4428	17	7	%	%	NOUN
gs-4428	17	8	reduction	reduction	NOUN
gs-4428	17	9	in	in	ADP
gs-4428	17	10	new	new	ADJ
gs-4428	17	11	chronic	chronic	ADJ
gs-4428	17	12	infections	infection	NOUN
gs-4428	17	13	and	and	CCONJ
gs-4428	17	14	a	a	DET
gs-4428	17	15	65	65	NUM
gs-4428	17	16	%	%	NOUN
gs-4428	17	17	reduction	reduction	NOUN
gs-4428	17	18	in	in	ADP
gs-4428	17	19	mortality	mortality	NOUN
gs-4428	17	20	compared	compare	VERB
gs-4428	17	21	with	with	ADP
gs-4428	17	22	2015	2015	NUM
gs-4428	17	23	levels	level	NOUN
gs-4428	17	24	(	(	PUNCT
gs-4428	17	25	world	world	NOUN
gs-4428	17	26	health	health	NOUN
gs-4428	17	27	organization	organization	PROPN
gs-4428	17	28	2022a	2022a	NUM
gs-4428	17	29	,	,	PUNCT
gs-4428	17	30	2022b	2022b	NUM
gs-4428	17	31	)	)	PUNCT
gs-4428	17	32	.	.	PUNCT
gs-4428	18	1	within	within	ADP
gs-4428	18	2	the	the	DET
gs-4428	18	3	who	who	PRON
gs-4428	18	4	european	european	PROPN
gs-4428	18	5	region	region	PROPN
gs-4428	18	6	,	,	PUNCT
gs-4428	18	7	georgia	georgia	PROPN
gs-4428	18	8	has	have	AUX
gs-4428	18	9	been	be	AUX
gs-4428	18	10	an	an	DET
gs-4428	18	11	early	early	ADJ
gs-4428	18	12	adopter	adopter	NOUN
gs-4428	18	13	of	of	ADP
gs-4428	18	14	hepatitis	hepatitis	NOUN
gs-4428	18	15	-	-	PUNCT
gs-4428	18	16	control	control	NOUN
gs-4428	18	17	initiatives	initiative	NOUN
gs-4428	18	18	.	.	PUNCT
gs-4428	19	1	the	the	DET
gs-4428	19	2	country	country	NOUN
gs-4428	19	3	introduced	introduce	VERB
gs-4428	19	4	infant	infant	NOUN
gs-4428	19	5	hepatitis	hepatitis	PROPN
gs-4428	19	6	b	b	PROPN
gs-4428	19	7	vaccination	vaccination	NOUN
gs-4428	19	8	in	in	ADP
gs-4428	19	9	2001	2001	NUM
gs-4428	19	10	and	and	CCONJ
gs-4428	19	11	the	the	DET
gs-4428	19	12	hepatitis	hepatitis	PROPN
gs-4428	19	13	b	b	PROPN
gs-4428	19	14	birth	birth	NOUN
gs-4428	19	15	dose	dose	NOUN
gs-4428	19	16	(	(	PUNCT
gs-4428	19	17	hepb	hepb	PROPN
gs-4428	19	18	-	-	PUNCT
gs-4428	19	19	bd	bd	NOUN
gs-4428	19	20	)	)	PUNCT
gs-4428	19	21	in	in	ADP
gs-4428	19	22	2003	2003	NUM
gs-4428	19	23	.	.	PUNCT
gs-4428	20	1	data	datum	NOUN
gs-4428	20	2	from	from	ADP
gs-4428	20	3	the	the	DET
gs-4428	20	4	who	who	PRON
gs-4428	20	5	/	/	SYM
gs-4428	20	6	unicef	unicef	PROPN
gs-4428	20	7	estimates	estimate	NOUN
gs-4428	20	8	of	of	ADP
gs-4428	20	9	national	national	ADJ
gs-4428	20	10	immunization	immunization	NOUN
gs-4428	20	11	coverage	coverage	NOUN
gs-4428	20	12	(	(	PUNCT
gs-4428	20	13	wuenic	wuenic	NOUN
gs-4428	20	14	)	)	PUNCT
gs-4428	20	15	show	show	VERB
gs-4428	20	16	that	that	SCONJ
gs-4428	20	17	both	both	CCONJ
gs-4428	20	18	the	the	DET
gs-4428	20	19	hepb	hepb	PROPN
gs-4428	20	20	-	-	PUNCT
gs-4428	20	21	bd	bd	PROPN
gs-4428	20	22	and	and	CCONJ
gs-4428	20	23	the	the	DET
gs-4428	20	24	three	three	NUM
gs-4428	20	25	-	-	PUNCT
gs-4428	20	26	dose	dose	VERB
gs-4428	20	27	infant	infant	NOUN
gs-4428	20	28	series	series	NOUN
gs-4428	20	29	(	(	PUNCT
gs-4428	20	30	hepb3	hepb3	PROPN
gs-4428	20	31	)	)	PUNCT
gs-4428	20	32	have	have	AUX
gs-4428	20	33	exceeded	exceed	VERB
gs-4428	20	34	90	90	NUM
gs-4428	20	35	%	%	NOUN
gs-4428	20	36	coverage	coverage	NOUN
gs-4428	20	37	for	for	ADP
gs-4428	20	38	most	most	ADJ
gs-4428	20	39	years	year	NOUN
gs-4428	20	40	of	of	ADP
gs-4428	20	41	the	the	DET
gs-4428	20	42	past	past	ADJ
gs-4428	20	43	decade	decade	NOUN
gs-4428	20	44	(	(	PUNCT
gs-4428	20	45	who	who	PRON
gs-4428	20	46	/	/	SYM
gs-4428	20	47	unicef	unicef	NOUN
gs-4428	20	48	2025	2025	NUM
gs-4428	20	49	)	)	PUNCT
gs-4428	20	50	.	.	PUNCT
gs-4428	21	1	in	in	ADP
gs-4428	21	2	addition	addition	NOUN
gs-4428	21	3	,	,	PUNCT
gs-4428	21	4	georgia	georgia	PROPN
gs-4428	21	5	implemented	implement	VERB
gs-4428	21	6	comprehensive	comprehensive	ADJ
gs-4428	21	7	prevention	prevention	NOUN
gs-4428	21	8	of	of	ADP
gs-4428	21	9	mother	mother	NOUN
gs-4428	21	10	-	-	PUNCT
gs-4428	21	11	to	to	ADP
gs-4428	21	12	-	-	PUNCT
gs-4428	21	13	child	child	NOUN
gs-4428	21	14	transmission	transmission	NOUN
gs-4428	21	15	(	(	PUNCT
gs-4428	21	16	pmtct	pmtct	NOUN
gs-4428	21	17	)	)	PUNCT
gs-4428	21	18	interventions	intervention	NOUN
gs-4428	21	19	within	within	ADP
gs-4428	21	20	maternal	maternal	ADJ
gs-4428	21	21	and	and	CCONJ
gs-4428	21	22	child	child	NOUN
gs-4428	21	23	health	health	NOUN
gs-4428	21	24	programs	program	NOUN
gs-4428	21	25	,	,	PUNCT
gs-4428	21	26	contributing	contribute	VERB
gs-4428	21	27	to	to	ADP
gs-4428	21	28	an	an	DET
gs-4428	21	29	extremely	extremely	ADV
gs-4428	21	30	low	low	ADJ
gs-4428	21	31	prevalence	prevalence	NOUN
gs-4428	21	32	of	of	ADP
gs-4428	21	33	infection	infection	NOUN
gs-4428	21	34	among	among	ADP
gs-4428	21	35	children	child	NOUN
gs-4428	21	36	.	.	PUNCT
gs-4428	22	1	two	two	NUM
gs-4428	22	2	nationwide	nationwide	ADJ
gs-4428	22	3	serosurveys	serosurvey	NOUN
gs-4428	22	4	illustrate	illustrate	VERB
gs-4428	22	5	this	this	DET
gs-4428	22	6	impact	impact	NOUN
gs-4428	22	7	.	.	PUNCT
gs-4428	23	1	the	the	DET
gs-4428	23	2	2015	2015	NUM
gs-4428	23	3	adult	adult	NOUN
gs-4428	23	4	survey	survey	NOUN
gs-4428	23	5	reported	report	VERB
gs-4428	23	6	hepatitis	hepatitis	PROPN
gs-4428	23	7	b	b	PROPN
gs-4428	23	8	surface	surface	NOUN
gs-4428	23	9	antigen	antigen	NOUN
gs-4428	23	10	(	(	PUNCT
gs-4428	23	11	hbsag	hbsag	NOUN
gs-4428	23	12	)	)	PUNCT
gs-4428	23	13	prevalence	prevalence	NOUN
gs-4428	23	14	at	at	ADP
gs-4428	23	15	2.9	2.9	NUM
gs-4428	23	16	%	%	NOUN
gs-4428	23	17	,	,	PUNCT
gs-4428	23	18	while	while	SCONJ
gs-4428	23	19	the	the	DET
gs-4428	23	20	2021	2021	NUM
gs-4428	23	21	survey	survey	NOUN
gs-4428	23	22	found	find	VERB
gs-4428	23	23	2.7	2.7	NUM
gs-4428	23	24	%	%	NOUN
gs-4428	23	25	among	among	ADP
gs-4428	23	26	adults	adult	NOUN
gs-4428	23	27	and	and	CCONJ
gs-4428	23	28	0.03	0.03	NUM
gs-4428	23	29	%	%	NOUN
gs-4428	23	30	among	among	ADP
gs-4428	23	31	children	child	NOUN
gs-4428	23	32	aged	age	VERB
gs-4428	23	33	5–17	5–17	NOUN
gs-4428	23	34	years	year	NOUN
gs-4428	23	35	,	,	PUNCT
gs-4428	23	36	demonstrating	demonstrate	VERB
gs-4428	23	37	near	near	ADJ
gs-4428	23	38	-	-	PUNCT
gs-4428	23	39	elimination	elimination	NOUN
gs-4428	23	40	of	of	ADP
gs-4428	23	41	pediatric	pediatric	ADJ
gs-4428	23	42	hepatitis	hepatitis	PROPN
gs-4428	23	43	b	b	PROPN
gs-4428	23	44	virus	virus	NOUN
gs-4428	23	45	(	(	PUNCT
gs-4428	23	46	hbv	hbv	NOUN
gs-4428	23	47	)	)	PUNCT
gs-4428	23	48	infection	infection	NOUN
gs-4428	23	49	(	(	PUNCT
gs-4428	23	50	kasradze	kasradze	PROPN
gs-4428	23	51	et	et	PROPN
gs-4428	23	52	al	al	PROPN
gs-4428	23	53	.	.	PROPN
gs-4428	23	54	2020	2020	NUM
gs-4428	23	55	;	;	PUNCT
gs-4428	23	56	khetsuriani	khetsuriani	PROPN
gs-4428	23	57	et	et	PROPN
gs-4428	23	58	al	al	PROPN
gs-4428	23	59	.	.	PROPN
gs-4428	23	60	2023	2023	NUM
gs-4428	23	61	;	;	PUNCT
gs-4428	23	62	tohme	tohme	NOUN
gs-4428	23	63	et	et	PROPN
gs-4428	23	64	al	al	PROPN
gs-4428	23	65	.	.	PROPN
gs-4428	23	66	2024	2024	NUM
gs-4428	23	67	)	)	PUNCT
gs-4428	23	68	.	.	PUNCT
gs-4428	24	1	despite	despite	SCONJ
gs-4428	24	2	strong	strong	ADJ
gs-4428	24	3	prevention	prevention	NOUN
gs-4428	24	4	indicators	indicator	NOUN
gs-4428	24	5	,	,	PUNCT
gs-4428	24	6	published	publish	VERB
gs-4428	24	7	and	and	CCONJ
gs-4428	24	8	program	program	NOUN
gs-4428	24	9	sources	source	NOUN
gs-4428	24	10	indicate	indicate	VERB
gs-4428	24	11	limited	limited	ADJ
gs-4428	24	12	monitoring	monitoring	NOUN
gs-4428	24	13	data	datum	NOUN
gs-4428	24	14	on	on	ADP
gs-4428	24	15	adult	adult	NOUN
gs-4428	24	16	hbsag	hbsag	NOUN
gs-4428	24	17	and	and	CCONJ
gs-4428	24	18	hbv	hbv	NOUN
gs-4428	24	19	dna	dna	PROPN
gs-4428	24	20	testing	testing	NOUN
gs-4428	24	21	,	,	PUNCT
gs-4428	24	22	non	non	ADJ
gs-4428	24	23	-	-	ADJ
gs-4428	24	24	invasive	invasive	ADJ
gs-4428	24	25	and	and	CCONJ
gs-4428	24	26	invasive	invasive	ADJ
gs-4428	24	27	fibrosis	fibrosis	NOUN
gs-4428	24	28	assessment	assessment	NOUN
gs-4428	24	29	(	(	PUNCT
gs-4428	24	30	transient	transient	ADJ
gs-4428	24	31	elastography	elastography	NOUN
gs-4428	24	32	and	and	CCONJ
gs-4428	24	33	liver	liver	NOUN
gs-4428	24	34	biopsy	biopsy	NOUN
gs-4428	24	35	)	)	PUNCT
gs-4428	24	36	,	,	PUNCT
gs-4428	24	37	and	and	CCONJ
gs-4428	24	38	antiviral	antiviral	ADJ
gs-4428	24	39	-	-	PUNCT
gs-4428	24	40	treatment	treatment	NOUN
gs-4428	24	41	coverage	coverage	NOUN
gs-4428	24	42	,	,	PUNCT
gs-4428	24	43	as	as	ADV
gs-4428	24	44	well	well	ADV
gs-4428	24	45	as	as	ADP
gs-4428	24	46	the	the	DET
gs-4428	24	47	absence	absence	NOUN
gs-4428	24	48	of	of	ADP
gs-4428	24	49	a	a	DET
gs-4428	24	50	national	national	ADJ
gs-4428	24	51	hbv	hbv	NOUN
gs-4428	24	52	treatment	treatment	NOUN
gs-4428	24	53	registry	registry	NOUN
gs-4428	24	54	(	(	PUNCT
gs-4428	24	55	coalition	coalition	NOUN
gs-4428	24	56	for	for	ADP
gs-4428	24	57	global	global	ADJ
gs-4428	24	58	hepatitis	hepatitis	NOUN
gs-4428	24	59	elimination	elimination	NOUN
gs-4428	24	60	2025	2025	NUM
gs-4428	24	61	;	;	PUNCT
gs-4428	24	62	tohme	tohme	PROPN
gs-4428	24	63	et	et	PROPN
gs-4428	24	64	al	al	PROPN
gs-4428	24	65	.	.	PROPN
gs-4428	24	66	2024	2024	NUM
gs-4428	24	67	)	)	PUNCT
gs-4428	24	68	.	.	PUNCT
gs-4428	25	1	understanding	understand	VERB
gs-4428	25	2	distributional	distributional	ADJ
gs-4428	25	3	differences	difference	NOUN
gs-4428	25	4	by	by	ADP
gs-4428	25	5	geography	geography	NOUN
gs-4428	25	6	,	,	PUNCT
gs-4428	25	7	age	age	NOUN
gs-4428	25	8	,	,	PUNCT
gs-4428	25	9	sex	sex	NOUN
gs-4428	25	10	,	,	PUNCT
gs-4428	25	11	and	and	CCONJ
gs-4428	25	12	key	key	ADJ
gs-4428	25	13	populations	population	NOUN
gs-4428	25	14	across	across	ADP
gs-4428	25	15	the	the	DET
gs-4428	25	16	prevention	prevention	NOUN
gs-4428	25	17	-	-	PUNCT
gs-4428	25	18	to	to	ADP
gs-4428	25	19	-	-	PUNCT
gs-4428	25	20	care	care	NOUN
gs-4428	25	21	cascade	cascade	NOUN
gs-4428	25	22	is	be	AUX
gs-4428	25	23	essential	essential	ADJ
gs-4428	25	24	to	to	PART
gs-4428	25	25	align	align	VERB
gs-4428	25	26	georgia	georgia	PROPN
gs-4428	25	27	’s	’s	PART
gs-4428	25	28	progress	progress	NOUN
gs-4428	25	29	with	with	ADP
gs-4428	25	30	ghss	ghss	PROPN
gs-4428	25	31	targets	target	NOUN
gs-4428	25	32	and	and	CCONJ
gs-4428	25	33	ensure	ensure	VERB
gs-4428	25	34	equitable	equitable	ADJ
gs-4428	25	35	access	access	NOUN
gs-4428	25	36	to	to	ADP
gs-4428	25	37	diagnosis	diagnosis	NOUN
gs-4428	25	38	and	and	CCONJ
gs-4428	25	39	treatment	treatment	NOUN
gs-4428	25	40	.	.	PUNCT
gs-4428	26	1	objective	objective	NOUN
gs-4428	26	2	:	:	PUNCT
gs-4428	26	3	to	to	PART
gs-4428	26	4	synthesize	synthesize	VERB
gs-4428	26	5	and	and	CCONJ
gs-4428	26	6	map	map	VERB
gs-4428	26	7	hbv	hbv	NOUN
gs-4428	26	8	evidence	evidence	NOUN
gs-4428	26	9	from	from	ADP
gs-4428	26	10	1	1	NUM
gs-4428	26	11	january	january	PROPN
gs-4428	26	12	2015	2015	NUM
gs-4428	26	13	to	to	ADP
gs-4428	26	14	30	30	NUM
gs-4428	26	15	september	september	PROPN
gs-4428	26	16	2025	2025	NUM
gs-4428	26	17	in	in	ADP
gs-4428	26	18	georgia	georgia	PROPN
gs-4428	26	19	—	—	PUNCT
gs-4428	26	20	covering	cover	VERB
gs-4428	26	21	epidemiology	epidemiology	NOUN
gs-4428	26	22	;	;	PUNCT
gs-4428	26	23	prevention	prevention	NOUN
gs-4428	26	24	through	through	ADP
gs-4428	26	25	vaccination	vaccination	NOUN
gs-4428	26	26	and	and	CCONJ
gs-4428	26	27	pmtct	pmtct	NOUN
gs-4428	26	28	;	;	PUNCT
gs-4428	26	29	the	the	DET
gs-4428	26	30	testing	testing	NOUN
gs-4428	26	31	–	–	PUNCT
gs-4428	26	32	treatment	treatment	NOUN
gs-4428	26	33	cascade	cascade	NOUN
gs-4428	26	34	;	;	PUNCT
gs-4428	26	35	and	and	CCONJ
gs-4428	26	36	equity	equity	NOUN
gs-4428	26	37	and	and	CCONJ
gs-4428	26	38	to	to	PART
gs-4428	26	39	identify	identify	VERB
gs-4428	26	40	progress	progress	NOUN
gs-4428	26	41	and	and	CCONJ
gs-4428	26	42	gaps	gap	NOUN
gs-4428	26	43	relative	relative	ADJ
gs-4428	26	44	to	to	ADP
gs-4428	26	45	who	who	PRON
gs-4428	26	46	ghss	ghss	VERB
gs-4428	26	47	2030	2030	NUM
gs-4428	26	48	targets	target	NOUN
gs-4428	26	49	.	.	PUNCT
gs-4428	27	1	methods	method	NOUN
gs-4428	27	2	review	review	VERB
gs-4428	27	3	design	design	NOUN
gs-4428	27	4	and	and	CCONJ
gs-4428	27	5	reporting	report	VERB
gs-4428	27	6	standard	standard	NOUN
gs-4428	27	7	this	this	DET
gs-4428	27	8	scoping	scoping	NOUN
gs-4428	27	9	review	review	NOUN
gs-4428	27	10	followed	follow	VERB
gs-4428	27	11	the	the	DET
gs-4428	27	12	methodological	methodological	ADJ
gs-4428	27	13	framework	framework	NOUN
gs-4428	27	14	of	of	ADP
gs-4428	27	15	arksey	arksey	NOUN
gs-4428	27	16	and	and	CCONJ
gs-4428	27	17	o’malley	o’malley	PROPN
gs-4428	27	18	(	(	PUNCT
gs-4428	27	19	2005	2005	NUM
gs-4428	27	20	)	)	PUNCT
gs-4428	27	21	and	and	CCONJ
gs-4428	27	22	was	be	AUX
gs-4428	27	23	reported	report	VERB
gs-4428	27	24	according	accord	VERB
gs-4428	27	25	to	to	ADP
gs-4428	27	26	the	the	DET
gs-4428	27	27	preferred	preferred	ADJ
gs-4428	27	28	reporting	reporting	NOUN
gs-4428	27	29	items	item	NOUN
gs-4428	27	30	for	for	ADP
gs-4428	27	31	systematic	systematic	ADJ
gs-4428	27	32	reviews	review	NOUN
gs-4428	27	33	and	and	CCONJ
gs-4428	27	34	meta	meta	ADJ
gs-4428	27	35	-	-	PUNCT
gs-4428	27	36	analyses	analysis	NOUN
gs-4428	27	37	extension	extension	NOUN
gs-4428	27	38	for	for	ADP
gs-4428	27	39	scoping	scope	VERB
gs-4428	27	40	reviews	review	NOUN
gs-4428	27	41	(	(	PUNCT
gs-4428	27	42	prisma	prisma	NOUN
gs-4428	27	43	-	-	PUNCT
gs-4428	27	44	scr	scr	NOUN
gs-4428	27	45	)	)	PUNCT
gs-4428	27	46	checklist	checklist	NOUN
gs-4428	27	47	(	(	PUNCT
gs-4428	27	48	tricco	tricco	PROPN
gs-4428	27	49	et	et	PROPN
gs-4428	27	50	al	al	PROPN
gs-4428	27	51	.	.	PUNCT
gs-4428	28	1	georgian	georgian	PROPN
gs-4428	28	2	scientists/	scientists/	NUM
gs-4428	28	3	.	.	PUNCT
gs-4428	29	1	7	7	NUM
gs-4428	29	2	n	n	DET
gs-4428	29	3	4	4	NUM
gs-4428	29	4	,	,	PUNCT
gs-4428	29	5	2025	2025	NUM
gs-4428	29	6	623	623	NUM
gs-4428	29	7	2018	2018	NUM
gs-4428	29	8	)	)	PUNCT
gs-4428	29	9	.	.	PUNCT
gs-4428	30	1	the	the	DET
gs-4428	30	2	review	review	NOUN
gs-4428	30	3	aimed	aim	VERB
gs-4428	30	4	to	to	PART
gs-4428	30	5	map	map	VERB
gs-4428	30	6	available	available	ADJ
gs-4428	30	7	evidence	evidence	NOUN
gs-4428	30	8	on	on	ADP
gs-4428	30	9	hbv	hbv	NOUN
gs-4428	30	10	in	in	ADP
gs-4428	30	11	georgia	georgia	PROPN
gs-4428	30	12	to	to	PART
gs-4428	30	13	inform	inform	VERB
gs-4428	30	14	national	national	ADJ
gs-4428	30	15	policy	policy	NOUN
gs-4428	30	16	within	within	ADP
gs-4428	30	17	the	the	DET
gs-4428	30	18	who	who	PRON
gs-4428	30	19	european	european	PROPN
gs-4428	30	20	region	region	NOUN
gs-4428	30	21	framework	framework	NOUN
gs-4428	30	22	.	.	PUNCT
gs-4428	31	1	eligibility	eligibility	NOUN
gs-4428	31	2	criteria	criterion	NOUN
gs-4428	31	3	we	we	PRON
gs-4428	31	4	included	include	VERB
gs-4428	31	5	sources	source	NOUN
gs-4428	31	6	published	publish	VERB
gs-4428	31	7	from	from	ADP
gs-4428	31	8	1	1	NUM
gs-4428	31	9	january	january	NOUN
gs-4428	31	10	2015	2015	NUM
gs-4428	31	11	to	to	ADP
gs-4428	31	12	30	30	NUM
gs-4428	31	13	september	september	PROPN
gs-4428	31	14	2025	2025	NUM
gs-4428	31	15	that	that	PRON
gs-4428	31	16	reported	report	VERB
gs-4428	31	17	data	datum	NOUN
gs-4428	31	18	from	from	ADP
gs-4428	31	19	georgia	georgia	PROPN
gs-4428	31	20	on	on	ADP
gs-4428	31	21	:	:	PUNCT
gs-4428	31	22	(	(	PUNCT
gs-4428	31	23	i	i	NOUN
gs-4428	31	24	)	)	PUNCT
gs-4428	31	25	hbv	hbv	NOUN
gs-4428	31	26	epidemiology	epidemiology	NOUN
gs-4428	31	27	,	,	PUNCT
gs-4428	31	28	including	include	VERB
gs-4428	31	29	hbsag	hbsag	NOUN
gs-4428	31	30	and/or	and/or	CCONJ
gs-4428	31	31	total	total	ADJ
gs-4428	31	32	hepatitis	hepatitis	PROPN
gs-4428	31	33	b	b	PROPN
gs-4428	31	34	core	core	NOUN
gs-4428	31	35	antibody	antibody	NOUN
gs-4428	31	36	(	(	PUNCT
gs-4428	31	37	anti	anti	ADJ
gs-4428	31	38	-	-	ADJ
gs-4428	31	39	hbc	hbc	ADJ
gs-4428	31	40	)	)	PUNCT
gs-4428	31	41	prevalence	prevalence	NOUN
gs-4428	31	42	;	;	PUNCT
gs-4428	31	43	(	(	PUNCT
gs-4428	31	44	ii	ii	NOUN
gs-4428	31	45	)	)	PUNCT
gs-4428	31	46	prevention	prevention	NOUN
gs-4428	31	47	indicators	indicator	NOUN
gs-4428	31	48	,	,	PUNCT
gs-4428	31	49	including	include	VERB
gs-4428	31	50	hepatitis	hepatitis	PROPN
gs-4428	31	51	b	b	PROPN
gs-4428	31	52	birth	birth	NOUN
gs-4428	31	53	dose	dose	NOUN
gs-4428	31	54	(	(	PUNCT
gs-4428	31	55	hepb	hepb	PROPN
gs-4428	31	56	-	-	PUNCT
gs-4428	31	57	bd	bd	PROPN
gs-4428	31	58	)	)	PUNCT
gs-4428	31	59	,	,	PUNCT
gs-4428	31	60	the	the	DET
gs-4428	31	61	three	three	NUM
gs-4428	31	62	-	-	PUNCT
gs-4428	31	63	dose	dose	VERB
gs-4428	31	64	infant	infant	NOUN
gs-4428	31	65	series	series	NOUN
gs-4428	31	66	(	(	PUNCT
gs-4428	31	67	hepb3	hepb3	NOUN
gs-4428	31	68	)	)	PUNCT
gs-4428	31	69	,	,	PUNCT
gs-4428	31	70	and	and	CCONJ
gs-4428	31	71	pmtct	pmtct	NOUN
gs-4428	31	72	;	;	PUNCT
gs-4428	31	73	(	(	PUNCT
gs-4428	31	74	iii	iii	X
gs-4428	31	75	)	)	PUNCT
gs-4428	31	76	the	the	DET
gs-4428	31	77	testing	testing	NOUN
gs-4428	31	78	–	–	PUNCT
gs-4428	31	79	treatment	treatment	NOUN
gs-4428	31	80	cascade	cascade	NOUN
gs-4428	31	81	,	,	PUNCT
gs-4428	31	82	including	include	VERB
gs-4428	31	83	proportions	proportion	NOUN
gs-4428	31	84	diagnosed	diagnose	VERB
gs-4428	31	85	,	,	PUNCT
gs-4428	31	86	eligible	eligible	ADJ
gs-4428	31	87	for	for	ADP
gs-4428	31	88	treatment	treatment	NOUN
gs-4428	31	89	,	,	PUNCT
gs-4428	31	90	and	and	CCONJ
gs-4428	31	91	treated	treat	VERB
gs-4428	31	92	;	;	PUNCT
gs-4428	31	93	and	and	CCONJ
gs-4428	31	94	(	(	PUNCT
gs-4428	31	95	iv	iv	X
gs-4428	31	96	)	)	PUNCT
gs-4428	31	97	equity	equity	NOUN
gs-4428	31	98	dimensions	dimension	NOUN
gs-4428	31	99	,	,	PUNCT
gs-4428	31	100	including	include	VERB
gs-4428	31	101	sex	sex	NOUN
gs-4428	31	102	,	,	PUNCT
gs-4428	31	103	age	age	NOUN
gs-4428	31	104	,	,	PUNCT
gs-4428	31	105	geography	geography	NOUN
gs-4428	31	106	,	,	PUNCT
gs-4428	31	107	and	and	CCONJ
gs-4428	31	108	key	key	ADJ
gs-4428	31	109	populations	population	NOUN
gs-4428	31	110	.	.	PUNCT
gs-4428	32	1	we	we	PRON
gs-4428	32	2	included	include	VERB
gs-4428	32	3	peerreviewed	peerreviewed	ADJ
gs-4428	32	4	studies	study	NOUN
gs-4428	32	5	(	(	PUNCT
gs-4428	32	6	observational	observational	ADJ
gs-4428	32	7	designs	design	NOUN
gs-4428	32	8	,	,	PUNCT
gs-4428	32	9	serosurveys	serosurvey	NOUN
gs-4428	32	10	,	,	PUNCT
gs-4428	32	11	and	and	CCONJ
gs-4428	32	12	program	program	NOUN
gs-4428	32	13	evaluations	evaluation	NOUN
gs-4428	32	14	)	)	PUNCT
gs-4428	32	15	and	and	CCONJ
gs-4428	32	16	authoritative	authoritative	ADJ
gs-4428	32	17	grey	grey	ADJ
gs-4428	32	18	literature	literature	NOUN
gs-4428	32	19	who	who	PRON
gs-4428	32	20	and	and	CCONJ
gs-4428	32	21	wuenic	wuenic	ADJ
gs-4428	32	22	,	,	PUNCT
gs-4428	32	23	u.s	u.s	PROPN
gs-4428	32	24	.	.	PROPN
gs-4428	32	25	centers	center	NOUN
gs-4428	32	26	for	for	ADP
gs-4428	32	27	disease	disease	NOUN
gs-4428	32	28	control	control	NOUN
gs-4428	32	29	and	and	CCONJ
gs-4428	32	30	prevention	prevention	NOUN
gs-4428	32	31	(	(	PUNCT
gs-4428	32	32	cdc	cdc	PROPN
gs-4428	32	33	)	)	PUNCT
gs-4428	32	34	,	,	PUNCT
gs-4428	32	35	coalition	coalition	NOUN
gs-4428	32	36	for	for	ADP
gs-4428	32	37	global	global	ADJ
gs-4428	32	38	hepatitis	hepatitis	NOUN
gs-4428	32	39	elimination	elimination	NOUN
gs-4428	32	40	(	(	PUNCT
gs-4428	32	41	cghe	cghe	NOUN
gs-4428	32	42	)	)	PUNCT
gs-4428	32	43	,	,	PUNCT
gs-4428	32	44	and	and	CCONJ
gs-4428	32	45	national	national	ADJ
gs-4428	32	46	or	or	CCONJ
gs-4428	32	47	partner	partner	NOUN
gs-4428	32	48	reports	report	NOUN
gs-4428	32	49	)	)	PUNCT
gs-4428	32	50	.	.	PUNCT
gs-4428	33	1	sources	source	NOUN
gs-4428	33	2	in	in	ADP
gs-4428	33	3	english	english	PROPN
gs-4428	33	4	or	or	CCONJ
gs-4428	33	5	georgian	georgian	PROPN
gs-4428	33	6	with	with	ADP
gs-4428	33	7	extractable	extractable	ADJ
gs-4428	33	8	data	datum	NOUN
gs-4428	33	9	were	be	AUX
gs-4428	33	10	eligible	eligible	ADJ
gs-4428	33	11	.	.	PUNCT
gs-4428	34	1	we	we	PRON
gs-4428	34	2	excluded	exclude	VERB
gs-4428	34	3	hepatitis	hepatitis	PROPN
gs-4428	34	4	c	c	PROPN
gs-4428	34	5	virus	virus	NOUN
gs-4428	34	6	(	(	PUNCT
gs-4428	34	7	hcv	hcv	PROPN
gs-4428	34	8	)	)	PUNCT
gs-4428	34	9	only	only	ADV
gs-4428	34	10	analyses	analysis	NOUN
gs-4428	34	11	,	,	PUNCT
gs-4428	34	12	case	case	NOUN
gs-4428	34	13	reports	report	NOUN
gs-4428	34	14	,	,	PUNCT
gs-4428	34	15	commentaries	commentary	NOUN
gs-4428	34	16	without	without	ADP
gs-4428	34	17	data	datum	NOUN
gs-4428	34	18	,	,	PUNCT
gs-4428	34	19	and	and	CCONJ
gs-4428	34	20	multinational	multinational	ADJ
gs-4428	34	21	studies	study	NOUN
gs-4428	34	22	without	without	ADP
gs-4428	34	23	disaggregated	disaggregate	VERB
gs-4428	34	24	georgian	georgian	PROPN
gs-4428	34	25	findings	finding	NOUN
gs-4428	34	26	.	.	PUNCT
gs-4428	35	1	information	information	NOUN
gs-4428	35	2	sources	source	NOUN
gs-4428	35	3	evidence	evidence	NOUN
gs-4428	35	4	was	be	AUX
gs-4428	35	5	retrieved	retrieve	VERB
gs-4428	35	6	from	from	ADP
gs-4428	35	7	medline	medline	NOUN
gs-4428	35	8	(	(	PUNCT
gs-4428	35	9	via	via	ADP
gs-4428	35	10	pubmed	pubmed	PROPN
gs-4428	35	11	)	)	PUNCT
gs-4428	35	12	,	,	PUNCT
gs-4428	35	13	embase	embase	NOUN
gs-4428	35	14	,	,	PUNCT
gs-4428	35	15	and	and	CCONJ
gs-4428	35	16	scopus	scopus	NOUN
gs-4428	35	17	.	.	PUNCT
gs-4428	36	1	grey	grey	ADJ
gs-4428	36	2	-	-	PUNCT
gs-4428	36	3	literature	literature	NOUN
gs-4428	36	4	sources	source	NOUN
gs-4428	36	5	comprised	comprise	VERB
gs-4428	36	6	who	who	PRON
gs-4428	36	7	hepatitis	hepatitis	NOUN
gs-4428	36	8	portals	portal	NOUN
gs-4428	36	9	and	and	CCONJ
gs-4428	36	10	ghss	ghss	PROPN
gs-4428	36	11	materials	material	NOUN
gs-4428	36	12	,	,	PUNCT
gs-4428	36	13	who	who	PRON
gs-4428	36	14	/	/	SYM
gs-4428	36	15	unicef	unicef	PROPN
gs-4428	36	16	wuenic	wuenic	ADJ
gs-4428	36	17	dashboards	dashboard	NOUN
gs-4428	36	18	,	,	PUNCT
gs-4428	36	19	the	the	DET
gs-4428	36	20	cdc	cdc	PROPN
gs-4428	36	21	hepatitis	hepatitis	PROPN
gs-4428	36	22	portal	portal	PROPN
gs-4428	36	23	and	and	CCONJ
gs-4428	36	24	morbidity	morbidity	NOUN
gs-4428	36	25	and	and	CCONJ
gs-4428	36	26	mortality	mortality	NOUN
gs-4428	36	27	weekly	weekly	ADJ
gs-4428	36	28	report	report	NOUN
gs-4428	36	29	(	(	PUNCT
gs-4428	36	30	mmwr	mmwr	NOUN
gs-4428	36	31	)	)	PUNCT
gs-4428	36	32	publications	publication	NOUN
gs-4428	36	33	,	,	PUNCT
gs-4428	36	34	cghe	cghe	ADJ
gs-4428	36	35	country	country	NOUN
gs-4428	36	36	profiles	profile	NOUN
gs-4428	36	37	,	,	PUNCT
gs-4428	36	38	and	and	CCONJ
gs-4428	36	39	publicly	publicly	ADV
gs-4428	36	40	available	available	ADJ
gs-4428	36	41	reports	report	NOUN
gs-4428	36	42	from	from	ADP
gs-4428	36	43	georgia	georgia	PROPN
gs-4428	36	44	’s	’s	PART
gs-4428	36	45	ministry	ministry	PROPN
gs-4428	36	46	of	of	ADP
gs-4428	36	47	health	health	PROPN
gs-4428	36	48	and	and	CCONJ
gs-4428	36	49	national	national	ADJ
gs-4428	36	50	center	center	NOUN
gs-4428	36	51	for	for	ADP
gs-4428	36	52	disease	disease	NOUN
gs-4428	36	53	control	control	NOUN
gs-4428	36	54	and	and	CCONJ
gs-4428	36	55	public	public	ADJ
gs-4428	36	56	health	health	NOUN
gs-4428	36	57	(	(	PUNCT
gs-4428	36	58	ncdc	ncdc	PROPN
gs-4428	36	59	)	)	PUNCT
gs-4428	36	60	(	(	PUNCT
gs-4428	36	61	who	who	PRON
gs-4428	36	62	/	/	SYM
gs-4428	36	63	unicef	unicef	PROPN
gs-4428	36	64	2025	2025	NUM
gs-4428	36	65	;	;	PUNCT
gs-4428	36	66	tohme	tohme	PROPN
gs-4428	36	67	et	et	PROPN
gs-4428	36	68	al	al	PROPN
gs-4428	36	69	.	.	PROPN
gs-4428	36	70	2024	2024	NUM
gs-4428	36	71	;	;	PUNCT
gs-4428	36	72	coalition	coalition	NOUN
gs-4428	36	73	for	for	ADP
gs-4428	36	74	global	global	ADJ
gs-4428	36	75	hepatitis	hepatitis	NOUN
gs-4428	36	76	elimination	elimination	NOUN
gs-4428	36	77	2025	2025	NUM
gs-4428	36	78	)	)	PUNCT
gs-4428	36	79	.	.	PUNCT
gs-4428	37	1	search	search	NOUN
gs-4428	37	2	strategy	strategy	NOUN
gs-4428	37	3	we	we	PRON
gs-4428	37	4	applied	apply	VERB
gs-4428	37	5	structured	structured	ADJ
gs-4428	37	6	boolean	boolean	ADJ
gs-4428	37	7	searches	search	NOUN
gs-4428	37	8	combining	combine	VERB
gs-4428	37	9	disease	disease	NOUN
gs-4428	37	10	,	,	PUNCT
gs-4428	37	11	country	country	NOUN
gs-4428	37	12	,	,	PUNCT
gs-4428	37	13	and	and	CCONJ
gs-4428	37	14	program	program	NOUN
gs-4428	37	15	terms	term	NOUN
gs-4428	37	16	.	.	PUNCT
gs-4428	38	1	the	the	DET
gs-4428	38	2	pubmed	pubmed	PROPN
gs-4428	38	3	strategy	strategy	NOUN
gs-4428	38	4	was	be	AUX
gs-4428	38	5	:	:	PUNCT
gs-4428	38	6	(	(	PUNCT
gs-4428	38	7	"	"	PUNCT
gs-4428	38	8	hepatitis	hepatitis	PROPN
gs-4428	38	9	b	b	NOUN
gs-4428	38	10	"	"	PUNCT
gs-4428	38	11	or	or	CCONJ
gs-4428	38	12	hbv	hbv	NOUN
gs-4428	38	13	or	or	CCONJ
gs-4428	38	14	"	"	PUNCT
gs-4428	38	15	hepatitis	hepatitis	PROPN
gs-4428	38	16	b	b	PROPN
gs-4428	38	17	virus	virus	NOUN
gs-4428	38	18	"	"	PUNCT
gs-4428	38	19	)	)	PUNCT
gs-4428	38	20	and	and	CCONJ
gs-4428	38	21	(	(	PUNCT
gs-4428	38	22	georgia	georgia	PROPN
gs-4428	38	23	[	[	X
gs-4428	38	24	tiab	tiab	X
gs-4428	38	25	]	]	X
gs-4428	38	26	or	or	CCONJ
gs-4428	38	27	georgian	georgian	PROPN
gs-4428	38	28	[	[	X
gs-4428	38	29	tiab	tiab	NOUN
gs-4428	38	30	]	]	X
gs-4428	38	31	)	)	PUNCT
gs-4428	38	32	and	and	CCONJ
gs-4428	38	33	(	(	PUNCT
gs-4428	38	34	prevalence	prevalence	NOUN
gs-4428	38	35	or	or	CCONJ
gs-4428	38	36	epidemiology	epidemiology	NOUN
gs-4428	38	37	or	or	CCONJ
gs-4428	38	38	vaccination	vaccination	NOUN
gs-4428	38	39	or	or	CCONJ
gs-4428	38	40	"	"	PUNCT
gs-4428	38	41	birth	birth	NOUN
gs-4428	38	42	dose	dose	NOUN
gs-4428	38	43	"	"	PUNCT
gs-4428	38	44	or	or	CCONJ
gs-4428	38	45	pmtct	pmtct	VERB
gs-4428	38	46	or	or	CCONJ
gs-4428	38	47	screening	screening	NOUN
gs-4428	38	48	or	or	CCONJ
gs-4428	38	49	diagnosis	diagnosis	NOUN
gs-4428	38	50	or	or	CCONJ
gs-4428	38	51	treatment	treatment	NOUN
gs-4428	38	52	or	or	CCONJ
gs-4428	38	53	cascade	cascade	NOUN
gs-4428	38	54	or	or	CCONJ
gs-4428	38	55	coverage	coverage	NOUN
gs-4428	38	56	or	or	CCONJ
gs-4428	38	57	elimination	elimination	NOUN
gs-4428	38	58	)	)	PUNCT
gs-4428	38	59	.	.	PUNCT
gs-4428	39	1	search	search	NOUN
gs-4428	39	2	strings	string	NOUN
gs-4428	39	3	were	be	AUX
gs-4428	39	4	adapted	adapt	VERB
gs-4428	39	5	for	for	ADP
gs-4428	39	6	embase	embase	NOUN
gs-4428	39	7	and	and	CCONJ
gs-4428	39	8	scopus	scopus	NOUN
gs-4428	39	9	.	.	PUNCT
gs-4428	40	1	grey	grey	ADJ
gs-4428	40	2	-	-	PUNCT
gs-4428	40	3	literature	literature	NOUN
gs-4428	40	4	queries	query	NOUN
gs-4428	40	5	used	use	VERB
gs-4428	40	6	platform	platform	NOUN
gs-4428	40	7	filters	filter	NOUN
gs-4428	40	8	(	(	PUNCT
gs-4428	40	9	for	for	ADP
gs-4428	40	10	example	example	NOUN
gs-4428	40	11	,	,	PUNCT
gs-4428	40	12	wuenic	wuenic	ADJ
gs-4428	40	13	,	,	PUNCT
gs-4428	40	14	country	country	NOUN
gs-4428	40	15	=	=	SYM
gs-4428	40	16	georgia	georgia	PROPN
gs-4428	40	17	;	;	PUNCT
gs-4428	40	18	u.s	u.s	PROPN
gs-4428	40	19	.	.	PROPN
gs-4428	40	20	cdc	cdc	PROPN
gs-4428	40	21	mmwr	mmwr	PROPN
gs-4428	40	22	keyword	keyword	PROPN
gs-4428	40	23	“	"	PUNCT
gs-4428	40	24	georgia	georgia	PROPN
gs-4428	40	25	hepatitis	hepatitis	PROPN
gs-4428	40	26	b	b	PROPN
gs-4428	40	27	”	"	PUNCT
gs-4428	40	28	)	)	PUNCT
gs-4428	40	29	.	.	PUNCT
gs-4428	41	1	selection	selection	NOUN
gs-4428	41	2	process	process	NOUN
gs-4428	41	3	titles	title	NOUN
gs-4428	41	4	and	and	CCONJ
gs-4428	41	5	abstracts	abstract	NOUN
gs-4428	41	6	were	be	AUX
gs-4428	41	7	screened	screen	VERB
gs-4428	41	8	independently	independently	ADV
gs-4428	41	9	by	by	ADP
gs-4428	41	10	two	two	NUM
gs-4428	41	11	reviewers	reviewer	NOUN
gs-4428	41	12	,	,	PUNCT
gs-4428	41	13	and	and	CCONJ
gs-4428	41	14	full	full	ADJ
gs-4428	41	15	texts	text	NOUN
gs-4428	41	16	were	be	AUX
gs-4428	41	17	assessed	assess	VERB
gs-4428	41	18	against	against	ADP
gs-4428	41	19	eligibility	eligibility	NOUN
gs-4428	41	20	criteria	criterion	NOUN
gs-4428	41	21	.	.	PUNCT
gs-4428	42	1	disagreements	disagreement	NOUN
gs-4428	42	2	were	be	AUX
gs-4428	42	3	resolved	resolve	VERB
gs-4428	42	4	through	through	ADP
gs-4428	42	5	discussion	discussion	NOUN
gs-4428	42	6	,	,	PUNCT
gs-4428	42	7	and	and	CCONJ
gs-4428	42	8	reasons	reason	NOUN
gs-4428	42	9	for	for	ADP
gs-4428	42	10	exclusion	exclusion	NOUN
gs-4428	42	11	at	at	ADP
gs-4428	42	12	the	the	DET
gs-4428	42	13	full	full	ADJ
gs-4428	42	14	-	-	PUNCT
gs-4428	42	15	text	text	NOUN
gs-4428	42	16	stage	stage	NOUN
gs-4428	42	17	were	be	AUX
gs-4428	42	18	documented	document	VERB
gs-4428	42	19	.	.	PUNCT
gs-4428	43	1	study	study	NOUN
gs-4428	43	2	selection	selection	NOUN
gs-4428	43	3	results	result	NOUN
gs-4428	43	4	were	be	AUX
gs-4428	43	5	summarized	summarize	VERB
gs-4428	43	6	in	in	ADP
gs-4428	43	7	a	a	DET
gs-4428	43	8	prisma	prisma	NOUN
gs-4428	43	9	-	-	PUNCT
gs-4428	43	10	scr	scr	NOUN
gs-4428	43	11	flow	flow	NOUN
gs-4428	43	12	diagram	diagram	NOUN
gs-4428	43	13	.	.	PUNCT
gs-4428	44	1	georgian	georgian	NOUN
gs-4428	44	2	scientists/	scientists/	NUM
gs-4428	44	3	.	.	PUNCT
gs-4428	45	1	7	7	NUM
gs-4428	45	2	n	n	DET
gs-4428	45	3	4	4	NUM
gs-4428	45	4	,	,	PUNCT
gs-4428	45	5	2025	2025	NUM
gs-4428	45	6	624	624	NUM
gs-4428	45	7	data	datum	NOUN
gs-4428	45	8	charting	charting	NOUN
gs-4428	45	9	and	and	CCONJ
gs-4428	45	10	variables	variable	NOUN
gs-4428	45	11	we	we	PRON
gs-4428	45	12	developed	develop	VERB
gs-4428	45	13	a	a	DET
gs-4428	45	14	standardized	standardized	ADJ
gs-4428	45	15	extraction	extraction	NOUN
gs-4428	45	16	form	form	NOUN
gs-4428	45	17	in	in	ADP
gs-4428	45	18	microsoft	microsoft	PROPN
gs-4428	45	19	excel	excel	VERB
gs-4428	45	20	capturing	capture	VERB
gs-4428	45	21	citation	citation	NOUN
gs-4428	45	22	,	,	PUNCT
gs-4428	45	23	year	year	NOUN
gs-4428	45	24	,	,	PUNCT
gs-4428	45	25	study	study	NOUN
gs-4428	45	26	design	design	NOUN
gs-4428	45	27	or	or	CCONJ
gs-4428	45	28	data	datum	NOUN
gs-4428	45	29	source	source	NOUN
gs-4428	45	30	,	,	PUNCT
gs-4428	45	31	population	population	NOUN
gs-4428	45	32	,	,	PUNCT
gs-4428	45	33	indicator	indicator	NOUN
gs-4428	45	34	values	value	NOUN
gs-4428	45	35	(	(	PUNCT
gs-4428	45	36	e.g.	e.g.	ADV
gs-4428	45	37	,	,	PUNCT
gs-4428	45	38	hbsag	hbsag	ADJ
gs-4428	45	39	prevalence	prevalence	NOUN
gs-4428	45	40	,	,	PUNCT
gs-4428	45	41	hepbbd	hepbbd	NOUN
gs-4428	45	42	/	/	SYM
gs-4428	45	43	hepb3	hepb3	NOUN
gs-4428	45	44	coverage	coverage	NOUN
gs-4428	45	45	,	,	PUNCT
gs-4428	45	46	proportions	proportion	NOUN
gs-4428	45	47	diagnosed	diagnose	VERB
gs-4428	45	48	or	or	CCONJ
gs-4428	45	49	treated	treat	VERB
gs-4428	45	50	)	)	PUNCT
gs-4428	45	51	,	,	PUNCT
gs-4428	45	52	equity	equity	NOUN
gs-4428	45	53	dimensions	dimension	NOUN
gs-4428	45	54	(	(	PUNCT
gs-4428	45	55	sex	sex	NOUN
gs-4428	45	56	,	,	PUNCT
gs-4428	45	57	age	age	NOUN
gs-4428	45	58	,	,	PUNCT
gs-4428	45	59	geography	geography	NOUN
gs-4428	45	60	,	,	PUNCT
gs-4428	45	61	and	and	CCONJ
gs-4428	45	62	key	key	ADJ
gs-4428	45	63	populations	population	NOUN
gs-4428	45	64	)	)	PUNCT
gs-4428	45	65	,	,	PUNCT
gs-4428	45	66	and	and	CCONJ
gs-4428	45	67	study	study	NOUN
gs-4428	45	68	limitations	limitation	NOUN
gs-4428	45	69	.	.	PUNCT
gs-4428	46	1	for	for	ADP
gs-4428	46	2	dynamic	dynamic	ADJ
gs-4428	46	3	grey	grey	NOUN
gs-4428	46	4	sources	source	NOUN
gs-4428	46	5	(	(	PUNCT
gs-4428	46	6	such	such	ADJ
gs-4428	46	7	as	as	ADP
gs-4428	46	8	who	who	PRON
gs-4428	46	9	or	or	CCONJ
gs-4428	46	10	wuenic	wuenic	ADJ
gs-4428	46	11	dashboards	dashboard	NOUN
gs-4428	46	12	)	)	PUNCT
gs-4428	46	13	,	,	PUNCT
gs-4428	46	14	extracted	extract	VERB
gs-4428	46	15	values	value	NOUN
gs-4428	46	16	were	be	AUX
gs-4428	46	17	cross	cross	ADJ
gs-4428	46	18	-	-	VERB
gs-4428	46	19	checked	check	VERB
gs-4428	46	20	with	with	ADP
gs-4428	46	21	the	the	DET
gs-4428	46	22	most	most	ADV
gs-4428	46	23	recent	recent	ADJ
gs-4428	46	24	version	version	NOUN
gs-4428	46	25	at	at	ADP
gs-4428	46	26	the	the	DET
gs-4428	46	27	time	time	NOUN
gs-4428	46	28	of	of	ADP
gs-4428	46	29	charting	charting	NOUN
gs-4428	46	30	to	to	PART
gs-4428	46	31	ensure	ensure	VERB
gs-4428	46	32	internal	internal	ADJ
gs-4428	46	33	consistency	consistency	NOUN
gs-4428	46	34	.	.	PUNCT
gs-4428	47	1	synthesis	synthesis	NOUN
gs-4428	47	2	and	and	CCONJ
gs-4428	47	3	presentation	presentation	NOUN
gs-4428	47	4	extracted	extract	VERB
gs-4428	47	5	data	datum	NOUN
gs-4428	47	6	were	be	AUX
gs-4428	47	7	summarized	summarize	VERB
gs-4428	47	8	narratively	narratively	ADV
gs-4428	47	9	and	and	CCONJ
gs-4428	47	10	organized	organize	VERB
gs-4428	47	11	into	into	ADP
gs-4428	47	12	four	four	NUM
gs-4428	47	13	domains	domain	NOUN
gs-4428	47	14	:	:	PUNCT
gs-4428	47	15	(	(	PUNCT
gs-4428	47	16	1	1	X
gs-4428	47	17	)	)	PUNCT
gs-4428	47	18	epidemiology	epidemiology	NOUN
gs-4428	47	19	;	;	PUNCT
gs-4428	47	20	(	(	PUNCT
gs-4428	47	21	2	2	X
gs-4428	47	22	)	)	PUNCT
gs-4428	47	23	vaccination	vaccination	NOUN
gs-4428	47	24	and	and	CCONJ
gs-4428	47	25	pmtct	pmtct	NOUN
gs-4428	47	26	;	;	PUNCT
gs-4428	47	27	(	(	PUNCT
gs-4428	47	28	3	3	X
gs-4428	47	29	)	)	PUNCT
gs-4428	47	30	testing	testing	NOUN
gs-4428	47	31	–	–	PUNCT
gs-4428	47	32	treatment	treatment	NOUN
gs-4428	47	33	cascade	cascade	NOUN
gs-4428	47	34	;	;	PUNCT
gs-4428	47	35	and	and	CCONJ
gs-4428	47	36	(	(	PUNCT
gs-4428	47	37	4	4	X
gs-4428	47	38	)	)	PUNCT
gs-4428	47	39	equity	equity	NOUN
gs-4428	47	40	.	.	PUNCT
gs-4428	48	1	indicator	indicator	NOUN
gs-4428	48	2	values	value	NOUN
gs-4428	48	3	were	be	AUX
gs-4428	48	4	benchmarked	benchmarke	VERB
gs-4428	48	5	against	against	ADP
gs-4428	48	6	the	the	PRON
gs-4428	48	7	who	who	PRON
gs-4428	48	8	ghss	ghss	VERB
gs-4428	48	9	2030	2030	NUM
gs-4428	48	10	targets	target	NOUN
gs-4428	48	11	and	and	CCONJ
gs-4428	48	12	wuenic	wuenic	ADJ
gs-4428	48	13	performance	performance	NOUN
gs-4428	48	14	thresholds	threshold	NOUN
gs-4428	48	15	(	(	PUNCT
gs-4428	48	16	world	world	NOUN
gs-4428	48	17	health	health	NOUN
gs-4428	48	18	organization	organization	PROPN
gs-4428	48	19	2022a	2022a	NUM
gs-4428	48	20	,	,	PUNCT
gs-4428	48	21	2022b	2022b	NUM
gs-4428	48	22	;	;	PUNCT
gs-4428	48	23	who	who	PRON
gs-4428	48	24	/	/	SYM
gs-4428	48	25	unicef	unicef	NOUN
gs-4428	48	26	2025	2025	NUM
gs-4428	48	27	)	)	PUNCT
gs-4428	48	28	.	.	PUNCT
gs-4428	49	1	descriptive	descriptive	ADJ
gs-4428	49	2	figures	figure	NOUN
gs-4428	49	3	including	include	VERB
gs-4428	49	4	evidence	evidence	NOUN
gs-4428	49	5	maps	map	NOUN
gs-4428	49	6	,	,	PUNCT
gs-4428	49	7	vaccination	vaccination	NOUN
gs-4428	49	8	coverage	coverage	NOUN
gs-4428	49	9	trends	trend	NOUN
gs-4428	49	10	,	,	PUNCT
gs-4428	49	11	and	and	CCONJ
gs-4428	49	12	cascade	cascade	NOUN
gs-4428	49	13	diagrams	diagram	NOUN
gs-4428	49	14	were	be	AUX
gs-4428	49	15	generated	generate	VERB
gs-4428	49	16	in	in	ADP
gs-4428	49	17	microsoft	microsoft	PROPN
gs-4428	49	18	excel	excel	PROPN
gs-4428	49	19	.	.	PUNCT
gs-4428	50	1	patient	patient	NOUN
gs-4428	50	2	and	and	CCONJ
gs-4428	50	3	public	public	ADJ
gs-4428	50	4	involvement	involvement	NOUN
gs-4428	50	5	no	no	DET
gs-4428	50	6	patients	patient	NOUN
gs-4428	50	7	or	or	CCONJ
gs-4428	50	8	members	member	NOUN
gs-4428	50	9	of	of	ADP
gs-4428	50	10	the	the	DET
gs-4428	50	11	public	public	NOUN
gs-4428	50	12	were	be	AUX
gs-4428	50	13	involved	involve	VERB
gs-4428	50	14	in	in	ADP
gs-4428	50	15	the	the	DET
gs-4428	50	16	design	design	NOUN
gs-4428	50	17	or	or	CCONJ
gs-4428	50	18	conduct	conduct	NOUN
gs-4428	50	19	of	of	ADP
gs-4428	50	20	this	this	DET
gs-4428	50	21	review	review	NOUN
gs-4428	50	22	.	.	PUNCT
gs-4428	51	1	results	result	VERB
gs-4428	51	2	epidemiology	epidemiology	NOUN
gs-4428	51	3	table	table	NOUN
gs-4428	51	4	1	1	NUM
gs-4428	51	5	summarizes	summarize	NOUN
gs-4428	51	6	key	key	ADJ
gs-4428	51	7	hepatitis	hepatitis	PROPN
gs-4428	51	8	b	b	PROPN
gs-4428	51	9	indicators	indicator	NOUN
gs-4428	51	10	in	in	ADP
gs-4428	51	11	georgia	georgia	PROPN
gs-4428	51	12	from	from	ADP
gs-4428	51	13	2015	2015	NUM
gs-4428	51	14	to	to	ADP
gs-4428	51	15	2025	2025	NUM
gs-4428	51	16	,	,	PUNCT
gs-4428	51	17	including	include	VERB
gs-4428	51	18	national	national	ADJ
gs-4428	51	19	estimates	estimate	NOUN
gs-4428	51	20	of	of	ADP
gs-4428	51	21	hbsag	hbsag	NOUN
gs-4428	51	22	and	and	CCONJ
gs-4428	51	23	total	total	ADJ
gs-4428	51	24	anti	anti	ADJ
gs-4428	51	25	-	-	ADJ
gs-4428	51	26	hbc	hbc	ADJ
gs-4428	51	27	prevalence	prevalence	NOUN
gs-4428	51	28	,	,	PUNCT
gs-4428	51	29	vaccination	vaccination	NOUN
gs-4428	51	30	and	and	CCONJ
gs-4428	51	31	pmtct	pmtct	NOUN
gs-4428	51	32	coverage	coverage	NOUN
gs-4428	51	33	,	,	PUNCT
gs-4428	51	34	testing	testing	NOUN
gs-4428	51	35	–	–	PUNCT
gs-4428	51	36	treatment	treatment	NOUN
gs-4428	51	37	cascade	cascade	NOUN
gs-4428	51	38	data	datum	NOUN
gs-4428	51	39	,	,	PUNCT
gs-4428	51	40	and	and	CCONJ
gs-4428	51	41	equity	equity	NOUN
gs-4428	51	42	-	-	PUNCT
gs-4428	51	43	related	relate	VERB
gs-4428	51	44	system	system	NOUN
gs-4428	51	45	indicators	indicator	NOUN
gs-4428	51	46	.	.	PUNCT
gs-4428	52	1	in	in	ADP
gs-4428	52	2	2015	2015	NUM
gs-4428	52	3	,	,	PUNCT
gs-4428	52	4	an	an	DET
gs-4428	52	5	adult	adult	NOUN
gs-4428	52	6	serosurvey	serosurvey	NOUN
gs-4428	52	7	among	among	ADP
gs-4428	52	8	individuals	individual	NOUN
gs-4428	52	9	aged	age	VERB
gs-4428	52	10	18	18	NUM
gs-4428	52	11	years	year	NOUN
gs-4428	52	12	reported	report	VERB
gs-4428	52	13	an	an	DET
gs-4428	52	14	hbsag	hbsag	ADJ
gs-4428	52	15	prevalence	prevalence	NOUN
gs-4428	52	16	of	of	ADP
gs-4428	52	17	2.9	2.9	NUM
gs-4428	52	18	%	%	NOUN
gs-4428	52	19	and	and	CCONJ
gs-4428	52	20	anti	anti	ADJ
gs-4428	52	21	-	-	ADJ
gs-4428	52	22	hbc	hbc	ADJ
gs-4428	52	23	prevalence	prevalence	NOUN
gs-4428	52	24	of	of	ADP
gs-4428	52	25	25.9	25.9	NUM
gs-4428	52	26	%	%	NOUN
gs-4428	52	27	(	(	PUNCT
gs-4428	52	28	kasradze	kasradze	PROPN
gs-4428	52	29	et	et	PROPN
gs-4428	52	30	al	al	PROPN
gs-4428	52	31	.	.	PROPN
gs-4428	52	32	2020	2020	NUM
gs-4428	52	33	)	)	PUNCT
gs-4428	52	34	.	.	PUNCT
gs-4428	53	1	the	the	DET
gs-4428	53	2	follow	follow	NOUN
gs-4428	53	3	-	-	PUNCT
gs-4428	53	4	up	up	NOUN
gs-4428	53	5	2021	2021	NUM
gs-4428	53	6	survey	survey	NOUN
gs-4428	53	7	showed	show	VERB
gs-4428	53	8	hbsag	hbsag	ADJ
gs-4428	53	9	2.7	2.7	NUM
gs-4428	53	10	%	%	NOUN
gs-4428	53	11	(	(	PUNCT
gs-4428	53	12	95	95	NUM
gs-4428	53	13	%	%	NOUN
gs-4428	53	14	ci	ci	NOUN
gs-4428	53	15	:	:	PUNCT
gs-4428	53	16	2.3–3.4	2.3–3.4	NUM
gs-4428	53	17	)	)	PUNCT
gs-4428	53	18	and	and	CCONJ
gs-4428	53	19	anti	anti	ADJ
gs-4428	53	20	-	-	ADJ
gs-4428	53	21	hbc	hbc	ADJ
gs-4428	53	22	21.7	21.7	NUM
gs-4428	53	23	%	%	NOUN
gs-4428	53	24	(	(	PUNCT
gs-4428	53	25	95	95	NUM
gs-4428	53	26	%	%	NOUN
gs-4428	53	27	ci	ci	NOUN
gs-4428	53	28	:	:	PUNCT
gs-4428	53	29	20.4–23.2	20.4–23.2	NUM
gs-4428	53	30	)	)	PUNCT
gs-4428	53	31	among	among	ADP
gs-4428	53	32	adults	adult	NOUN
gs-4428	53	33	;	;	PUNCT
gs-4428	53	34	among	among	ADP
gs-4428	53	35	children	child	NOUN
gs-4428	53	36	aged	age	VERB
gs-4428	53	37	5–17	5–17	NOUN
gs-4428	53	38	years	year	NOUN
gs-4428	53	39	,	,	PUNCT
gs-4428	53	40	hbsag	hbsag	NOUN
gs-4428	53	41	was	be	AUX
gs-4428	53	42	0.03	0.03	NUM
gs-4428	53	43	%	%	NOUN
gs-4428	53	44	(	(	PUNCT
gs-4428	53	45	95	95	NUM
gs-4428	53	46	%	%	NOUN
gs-4428	53	47	ci	ci	NOUN
gs-4428	53	48	:	:	PUNCT
gs-4428	53	49	0.0–0.19	0.0–0.19	NUM
gs-4428	53	50	)	)	PUNCT
gs-4428	53	51	and	and	CCONJ
gs-4428	53	52	antihbc	antihbc	PROPN
gs-4428	53	53	0.7	0.7	NUM
gs-4428	53	54	%	%	NOUN
gs-4428	53	55	(	(	PUNCT
gs-4428	53	56	95	95	NUM
gs-4428	53	57	%	%	NOUN
gs-4428	53	58	ci	ci	NOUN
gs-4428	53	59	:	:	PUNCT
gs-4428	53	60	0.3–1.6	0.3–1.6	NOUN
gs-4428	53	61	)	)	PUNCT
gs-4428	54	1	(	(	PUNCT
gs-4428	54	2	khetsuriani	khetsuriani	NOUN
gs-4428	54	3	et	et	PROPN
gs-4428	54	4	al	al	PROPN
gs-4428	54	5	.	.	PROPN
gs-4428	54	6	2023	2023	NUM
gs-4428	54	7	)	)	PUNCT
gs-4428	54	8	.	.	PUNCT
gs-4428	55	1	these	these	DET
gs-4428	55	2	findings	finding	NOUN
gs-4428	55	3	confirm	confirm	VERB
gs-4428	55	4	nearelimination	nearelimination	NOUN
gs-4428	55	5	of	of	ADP
gs-4428	55	6	pediatric	pediatric	ADJ
gs-4428	55	7	infection	infection	NOUN
gs-4428	55	8	,	,	PUNCT
gs-4428	55	9	consistent	consistent	ADJ
gs-4428	55	10	with	with	ADP
gs-4428	55	11	sustained	sustained	ADJ
gs-4428	55	12	high	high	ADJ
gs-4428	55	13	hepb	hepb	NOUN
gs-4428	55	14	-	-	PUNCT
gs-4428	55	15	bd	bd	PROPN
gs-4428	55	16	and	and	CCONJ
gs-4428	55	17	hepb3	hepb3	NOUN
gs-4428	55	18	coverage	coverage	NOUN
gs-4428	55	19	,	,	PUNCT
gs-4428	55	20	while	while	SCONJ
gs-4428	55	21	adult	adult	NOUN
gs-4428	55	22	prevalence	prevalence	NOUN
gs-4428	55	23	remains	remain	VERB
gs-4428	55	24	similar	similar	ADJ
gs-4428	55	25	to	to	ADP
gs-4428	55	26	2015	2015	NUM
gs-4428	55	27	,	,	PUNCT
gs-4428	55	28	indicating	indicate	VERB
gs-4428	55	29	a	a	DET
gs-4428	55	30	persistent	persistent	ADJ
gs-4428	55	31	reservoir	reservoir	NOUN
gs-4428	55	32	in	in	ADP
gs-4428	55	33	older	old	ADJ
gs-4428	55	34	cohorts	cohort	NOUN
gs-4428	55	35	(	(	PUNCT
gs-4428	55	36	khetsuriani	khetsuriani	X
gs-4428	55	37	et	et	PROPN
gs-4428	55	38	al	al	PROPN
gs-4428	55	39	.	.	PROPN
gs-4428	55	40	2023	2023	NUM
gs-4428	55	41	;	;	PUNCT
gs-4428	55	42	tohme	tohme	NOUN
gs-4428	55	43	et	et	PROPN
gs-4428	55	44	al	al	PROPN
gs-4428	55	45	.	.	PROPN
gs-4428	55	46	2024	2024	NUM
gs-4428	55	47	)	)	PUNCT
gs-4428	55	48	.	.	PUNCT
gs-4428	56	1	prevention	prevention	NOUN
gs-4428	56	2	(	(	PUNCT
gs-4428	56	3	vaccination	vaccination	NOUN
gs-4428	56	4	and	and	CCONJ
gs-4428	56	5	pmtct	pmtct	NOUN
gs-4428	56	6	)	)	PUNCT
gs-4428	56	7	georgia	georgia	PROPN
gs-4428	56	8	has	have	AUX
gs-4428	56	9	maintained	maintain	VERB
gs-4428	56	10	high	high	ADJ
gs-4428	56	11	hepatitis	hepatitis	NOUN
gs-4428	56	12	b	b	NOUN
gs-4428	56	13	vaccination	vaccination	NOUN
gs-4428	56	14	coverage	coverage	NOUN
gs-4428	56	15	for	for	ADP
gs-4428	56	16	more	more	ADJ
gs-4428	56	17	than	than	ADP
gs-4428	56	18	a	a	PRON
gs-4428	56	19	decade	decade	NOUN
gs-4428	56	20	.	.	PUNCT
gs-4428	57	1	according	accord	VERB
gs-4428	57	2	to	to	ADP
gs-4428	57	3	wuenic	wuenic	NOUN
gs-4428	57	4	,	,	PUNCT
gs-4428	57	5	the	the	DET
gs-4428	57	6	three	three	NUM
gs-4428	57	7	-	-	PUNCT
gs-4428	57	8	dose	dose	VERB
gs-4428	57	9	infant	infant	NOUN
gs-4428	57	10	series	series	NOUN
gs-4428	57	11	(	(	PUNCT
gs-4428	57	12	hepb3	hepb3	NOUN
gs-4428	57	13	)	)	PUNCT
gs-4428	57	14	coverage	coverage	NOUN
gs-4428	57	15	ranged	range	VERB
gs-4428	57	16	from	from	ADP
gs-4428	57	17	94	94	NUM
gs-4428	57	18	%	%	NOUN
gs-4428	57	19	to	to	ADP
gs-4428	57	20	98	98	NUM
gs-4428	57	21	%	%	NOUN
gs-4428	57	22	between	between	ADP
gs-4428	57	23	2015	2015	NUM
gs-4428	57	24	and	and	CCONJ
gs-4428	57	25	2024	2024	NUM
gs-4428	57	26	,	,	PUNCT
gs-4428	57	27	while	while	SCONJ
gs-4428	57	28	timely	timely	ADJ
gs-4428	57	29	administration	administration	NOUN
gs-4428	57	30	of	of	ADP
gs-4428	57	31	the	the	DET
gs-4428	57	32	birth	birth	NOUN
gs-4428	57	33	dose	dose	NOUN
gs-4428	57	34	(	(	PUNCT
gs-4428	57	35	hepb	hepb	PROPN
gs-4428	57	36	-	-	PUNCT
gs-4428	57	37	bd	bd	NOUN
gs-4428	57	38	)	)	PUNCT
gs-4428	57	39	ranged	range	VERB
gs-4428	57	40	from	from	ADP
gs-4428	57	41	90	90	NUM
gs-4428	57	42	%	%	NOUN
gs-4428	57	43	to	to	ADP
gs-4428	57	44	96	96	NUM
gs-4428	57	45	%	%	NOUN
gs-4428	57	46	(	(	PUNCT
gs-4428	57	47	who	who	PRON
gs-4428	57	48	/	/	SYM
gs-4428	57	49	unicef	unicef	NOUN
gs-4428	57	50	2025	2025	NUM
gs-4428	57	51	)	)	PUNCT
gs-4428	57	52	.	.	PUNCT
gs-4428	58	1	these	these	DET
gs-4428	58	2	levels	level	NOUN
gs-4428	58	3	exceed	exceed	VERB
gs-4428	58	4	the	the	PRON
gs-4428	58	5	who	who	PRON
gs-4428	58	6	ghss	ghss	VERB
gs-4428	58	7	2030	2030	NUM
gs-4428	58	8	targets	target	NOUN
gs-4428	58	9	of	of	ADP
gs-4428	58	10	90	90	NUM
gs-4428	58	11	%	%	NOUN
gs-4428	58	12	for	for	ADP
gs-4428	58	13	both	both	DET
gs-4428	58	14	indicators	indicator	NOUN
gs-4428	58	15	and	and	CCONJ
gs-4428	58	16	align	align	VERB
gs-4428	58	17	with	with	ADP
gs-4428	58	18	the	the	DET
gs-4428	58	19	near	near	ADV
gs-4428	58	20	-	-	PUNCT
gs-4428	58	21	zero	zero	NUM
gs-4428	58	22	hbsag	hbsag	ADJ
gs-4428	58	23	prevalence	prevalence	NOUN
gs-4428	58	24	among	among	ADP
gs-4428	58	25	children	child	NOUN
gs-4428	58	26	in	in	ADP
gs-4428	58	27	the	the	DET
gs-4428	58	28	2021	2021	NUM
gs-4428	58	29	serosurvey	serosurvey	NOUN
gs-4428	58	30	.	.	PUNCT
gs-4428	59	1	georgian	georgian	NOUN
gs-4428	59	2	scientists/	scientists/	NUM
gs-4428	59	3	.	.	PUNCT
gs-4428	60	1	7	7	NUM
gs-4428	60	2	n	n	DET
gs-4428	60	3	4	4	NUM
gs-4428	60	4	,	,	PUNCT
gs-4428	60	5	2025	2025	NUM
gs-4428	60	6	625	625	NUM
gs-4428	60	7	pmtct	pmtct	NOUN
gs-4428	60	8	has	have	AUX
gs-4428	60	9	been	be	AUX
gs-4428	60	10	progressively	progressively	ADV
gs-4428	60	11	integrated	integrate	VERB
gs-4428	60	12	into	into	ADP
gs-4428	60	13	georgia	georgia	PROPN
gs-4428	60	14	’s	’s	PART
gs-4428	60	15	maternal	maternal	ADJ
gs-4428	60	16	and	and	CCONJ
gs-4428	60	17	child	child	NOUN
gs-4428	60	18	health	health	NOUN
gs-4428	60	19	services	service	NOUN
gs-4428	60	20	.	.	PUNCT
gs-4428	61	1	national	national	PROPN
gs-4428	61	2	pmtct	pmtct	PROPN
gs-4428	61	3	guidelines	guideline	NOUN
gs-4428	61	4	recommend	recommend	VERB
gs-4428	61	5	universal	universal	ADJ
gs-4428	61	6	antenatal	antenatal	ADJ
gs-4428	61	7	hbsag	hbsag	NOUN
gs-4428	61	8	screening	screening	NOUN
gs-4428	61	9	,	,	PUNCT
gs-4428	61	10	administration	administration	NOUN
gs-4428	61	11	of	of	ADP
gs-4428	61	12	hepatitis	hepatitis	PROPN
gs-4428	61	13	b	b	PROPN
gs-4428	61	14	vaccine	vaccine	NOUN
gs-4428	61	15	and	and	CCONJ
gs-4428	61	16	hepatitis	hepatitis	PROPN
gs-4428	61	17	b	b	PROPN
gs-4428	61	18	immune	immune	ADJ
gs-4428	61	19	globulin	globulin	NOUN
gs-4428	61	20	(	(	PUNCT
gs-4428	61	21	hbig	hbig	X
gs-4428	61	22	)	)	PUNCT
gs-4428	61	23	to	to	ADP
gs-4428	61	24	infants	infant	NOUN
gs-4428	61	25	born	bear	VERB
gs-4428	61	26	to	to	ADP
gs-4428	61	27	hbsag	hbsag	ADJ
gs-4428	61	28	-	-	PUNCT
gs-4428	61	29	positive	positive	ADJ
gs-4428	61	30	mothers	mother	NOUN
gs-4428	61	31	,	,	PUNCT
gs-4428	61	32	and	and	CCONJ
gs-4428	61	33	post	post	ADJ
gs-4428	61	34	-	-	ADJ
gs-4428	61	35	vaccination	vaccination	ADJ
gs-4428	61	36	serologic	serologic	NOUN
gs-4428	61	37	testing	testing	NOUN
gs-4428	61	38	when	when	SCONJ
gs-4428	61	39	feasible	feasible	ADJ
gs-4428	61	40	.	.	PUNCT
gs-4428	62	1	implementation	implementation	NOUN
gs-4428	62	2	reports	report	NOUN
gs-4428	62	3	from	from	ADP
gs-4428	62	4	the	the	DET
gs-4428	62	5	ncdc	ncdc	NOUN
gs-4428	62	6	and	and	CCONJ
gs-4428	62	7	the	the	DET
gs-4428	62	8	ministry	ministry	PROPN
gs-4428	62	9	of	of	ADP
gs-4428	62	10	health	health	PROPN
gs-4428	62	11	indicate	indicate	VERB
gs-4428	62	12	increasing	increase	VERB
gs-4428	62	13	coverage	coverage	NOUN
gs-4428	62	14	of	of	ADP
gs-4428	62	15	antenatal	antenatal	NOUN
gs-4428	62	16	screening	screening	NOUN
gs-4428	62	17	and	and	CCONJ
gs-4428	62	18	timely	timely	ADJ
gs-4428	62	19	post	post	ADJ
gs-4428	62	20	-	-	ADJ
gs-4428	62	21	exposure	exposure	ADJ
gs-4428	62	22	prophylaxis	prophylaxis	NOUN
gs-4428	62	23	in	in	ADP
gs-4428	62	24	maternity	maternity	NOUN
gs-4428	62	25	facilities	facility	NOUN
gs-4428	62	26	nationwide	nationwide	ADV
gs-4428	62	27	(	(	PUNCT
gs-4428	62	28	ncdc	ncdc	PROPN
gs-4428	62	29	2024	2024	NUM
gs-4428	62	30	;	;	PUNCT
gs-4428	62	31	world	world	NOUN
gs-4428	62	32	health	health	NOUN
gs-4428	62	33	organization	organization	NOUN
gs-4428	62	34	2024	2024	NUM
gs-4428	62	35	)	)	PUNCT
gs-4428	62	36	.	.	PUNCT
gs-4428	63	1	collectively	collectively	ADV
gs-4428	63	2	,	,	PUNCT
gs-4428	63	3	these	these	DET
gs-4428	63	4	data	datum	NOUN
gs-4428	63	5	confirm	confirm	VERB
gs-4428	63	6	that	that	SCONJ
gs-4428	63	7	georgia	georgia	PROPN
gs-4428	63	8	has	have	AUX
gs-4428	63	9	achieved	achieve	VERB
gs-4428	63	10	and	and	CCONJ
gs-4428	63	11	sustained	sustain	VERB
gs-4428	63	12	high	high	ADJ
gs-4428	63	13	levels	level	NOUN
gs-4428	63	14	of	of	ADP
gs-4428	63	15	vaccination	vaccination	NOUN
gs-4428	63	16	and	and	CCONJ
gs-4428	63	17	perinatal	perinatal	ADJ
gs-4428	63	18	prevention	prevention	NOUN
gs-4428	63	19	,	,	PUNCT
gs-4428	63	20	contributing	contribute	VERB
gs-4428	63	21	to	to	ADP
gs-4428	63	22	the	the	DET
gs-4428	63	23	virtual	virtual	ADJ
gs-4428	63	24	elimination	elimination	NOUN
gs-4428	63	25	of	of	ADP
gs-4428	63	26	hbv	hbv	NOUN
gs-4428	63	27	infection	infection	NOUN
gs-4428	63	28	among	among	ADP
gs-4428	63	29	children	child	NOUN
gs-4428	63	30	born	bear	VERB
gs-4428	63	31	after	after	ADP
gs-4428	63	32	2003	2003	NUM
gs-4428	63	33	.	.	PUNCT
gs-4428	64	1	remaining	remain	VERB
gs-4428	64	2	challenges	challenge	NOUN
gs-4428	64	3	include	include	VERB
gs-4428	64	4	maintaining	maintain	VERB
gs-4428	64	5	uniform	uniform	ADJ
gs-4428	64	6	birth	birth	NOUN
gs-4428	64	7	-	-	PUNCT
gs-4428	64	8	dose	dose	VERB
gs-4428	64	9	timeliness	timeliness	NOUN
gs-4428	64	10	in	in	ADP
gs-4428	64	11	remote	remote	ADJ
gs-4428	64	12	areas	area	NOUN
gs-4428	64	13	,	,	PUNCT
gs-4428	64	14	ensuring	ensure	VERB
gs-4428	64	15	adequate	adequate	ADJ
gs-4428	64	16	hbig	hbig	ADJ
gs-4428	64	17	supply	supply	NOUN
gs-4428	64	18	,	,	PUNCT
gs-4428	64	19	and	and	CCONJ
gs-4428	64	20	extending	extend	VERB
gs-4428	64	21	pmtct	pmtct	ADJ
gs-4428	64	22	follow	follow	NOUN
gs-4428	64	23	-	-	PUNCT
gs-4428	64	24	up	up	ADP
gs-4428	64	25	systems	system	NOUN
gs-4428	64	26	to	to	PART
gs-4428	64	27	monitor	monitor	VERB
gs-4428	64	28	post	post	ADJ
gs-4428	64	29	-	-	ADJ
gs-4428	64	30	vaccination	vaccination	ADJ
gs-4428	64	31	seroprotection	seroprotection	NOUN
gs-4428	64	32	rates	rate	NOUN
gs-4428	64	33	.	.	PUNCT
gs-4428	65	1	testing	testing	NOUN
gs-4428	65	2	–	–	PUNCT
gs-4428	65	3	treatment	treatment	NOUN
gs-4428	65	4	cascade	cascade	NOUN
gs-4428	65	5	published	publish	VERB
gs-4428	65	6	and	and	CCONJ
gs-4428	65	7	programmatic	programmatic	ADJ
gs-4428	65	8	evidence	evidence	NOUN
gs-4428	65	9	reveals	reveal	VERB
gs-4428	65	10	that	that	SCONJ
gs-4428	65	11	while	while	SCONJ
gs-4428	65	12	vaccination	vaccination	NOUN
gs-4428	65	13	and	and	CCONJ
gs-4428	65	14	pediatric	pediatric	ADJ
gs-4428	65	15	control	control	NOUN
gs-4428	65	16	are	be	AUX
gs-4428	65	17	well	well	ADV
gs-4428	65	18	established	establish	VERB
gs-4428	65	19	,	,	PUNCT
gs-4428	65	20	adult	adult	NOUN
gs-4428	65	21	hbv	hbv	NOUN
gs-4428	65	22	diagnosis	diagnosis	NOUN
gs-4428	65	23	and	and	CCONJ
gs-4428	65	24	treatment	treatment	NOUN
gs-4428	65	25	coverage	coverage	NOUN
gs-4428	65	26	remain	remain	VERB
gs-4428	65	27	limited	limited	ADJ
gs-4428	65	28	.	.	PUNCT
gs-4428	66	1	the	the	DET
gs-4428	66	2	2024	2024	NUM
gs-4428	66	3	cdc	cdc	PROPN
gs-4428	66	4	morbidity	morbidity	NOUN
gs-4428	66	5	and	and	CCONJ
gs-4428	66	6	mortality	mortality	NOUN
gs-4428	66	7	weekly	weekly	ADJ
gs-4428	66	8	report	report	NOUN
gs-4428	66	9	(	(	PUNCT
gs-4428	66	10	mmwr	mmwr	NOUN
gs-4428	66	11	)	)	PUNCT
gs-4428	66	12	report	report	NOUN
gs-4428	66	13	estimated	estimate	VERB
gs-4428	66	14	that	that	SCONJ
gs-4428	66	15	only	only	ADV
gs-4428	66	16	about	about	ADV
gs-4428	66	17	25	25	NUM
gs-4428	66	18	%	%	NOUN
gs-4428	66	19	of	of	ADP
gs-4428	66	20	persons	person	NOUN
gs-4428	66	21	with	with	ADP
gs-4428	66	22	chronic	chronic	ADJ
gs-4428	66	23	hbv	hbv	NOUN
gs-4428	66	24	infection	infection	NOUN
gs-4428	66	25	in	in	ADP
gs-4428	66	26	georgia	georgia	PROPN
gs-4428	66	27	had	have	AUX
gs-4428	66	28	been	be	AUX
gs-4428	66	29	diagnosed	diagnose	VERB
gs-4428	66	30	and	and	CCONJ
gs-4428	66	31	approximately	approximately	ADV
gs-4428	66	32	5	5	NUM
gs-4428	66	33	%	%	NOUN
gs-4428	66	34	had	have	AUX
gs-4428	66	35	initiated	initiate	VERB
gs-4428	66	36	antiviral	antiviral	ADJ
gs-4428	66	37	therapy	therapy	NOUN
gs-4428	66	38	(	(	PUNCT
gs-4428	66	39	tohme	tohme	NOUN
gs-4428	66	40	et	et	PROPN
gs-4428	66	41	al	al	PROPN
gs-4428	66	42	.	.	PROPN
gs-4428	66	43	2024	2024	NUM
gs-4428	66	44	)	)	PUNCT
gs-4428	66	45	.	.	PUNCT
gs-4428	67	1	the	the	DET
gs-4428	67	2	coalition	coalition	NOUN
gs-4428	67	3	for	for	ADP
gs-4428	67	4	global	global	ADJ
gs-4428	67	5	hepatitis	hepatitis	NOUN
gs-4428	67	6	elimination	elimination	NOUN
gs-4428	67	7	(	(	PUNCT
gs-4428	67	8	cghe	cghe	NOUN
gs-4428	67	9	2025	2025	NUM
gs-4428	67	10	)	)	PUNCT
gs-4428	67	11	country	country	NOUN
gs-4428	67	12	profile	profile	NOUN
gs-4428	67	13	likewise	likewise	ADV
gs-4428	67	14	reported	report	VERB
gs-4428	67	15	that	that	SCONJ
gs-4428	67	16	hbv	hbv	NOUN
gs-4428	67	17	diagnosis	diagnosis	NOUN
gs-4428	67	18	and	and	CCONJ
gs-4428	67	19	treatment	treatment	NOUN
gs-4428	67	20	monitoring	monitoring	NOUN
gs-4428	67	21	systems	system	NOUN
gs-4428	67	22	were	be	AUX
gs-4428	67	23	not	not	PART
gs-4428	67	24	yet	yet	ADV
gs-4428	67	25	fully	fully	ADV
gs-4428	67	26	implemented	implement	VERB
gs-4428	67	27	.	.	PUNCT
gs-4428	68	1	no	no	DET
gs-4428	68	2	national	national	ADJ
gs-4428	68	3	registry	registry	NOUN
gs-4428	68	4	exists	exist	VERB
gs-4428	68	5	for	for	ADP
gs-4428	68	6	treatment	treatment	NOUN
gs-4428	68	7	tracking	tracking	NOUN
gs-4428	68	8	or	or	CCONJ
gs-4428	68	9	longitudinal	longitudinal	ADJ
gs-4428	68	10	clinical	clinical	ADJ
gs-4428	68	11	monitoring	monitoring	NOUN
gs-4428	68	12	.	.	PUNCT
gs-4428	69	1	available	available	ADJ
gs-4428	69	2	program	program	NOUN
gs-4428	69	3	data	datum	NOUN
gs-4428	69	4	from	from	ADP
gs-4428	69	5	pilot	pilot	NOUN
gs-4428	69	6	clinics	clinic	NOUN
gs-4428	69	7	suggest	suggest	VERB
gs-4428	69	8	that	that	SCONJ
gs-4428	69	9	tenofovir	tenofovir	NOUN
gs-4428	69	10	and	and	CCONJ
gs-4428	69	11	entecavir	entecavir	NOUN
gs-4428	69	12	are	be	AUX
gs-4428	69	13	the	the	DET
gs-4428	69	14	most	most	ADV
gs-4428	69	15	commonly	commonly	ADV
gs-4428	69	16	used	use	VERB
gs-4428	69	17	first	first	ADJ
gs-4428	69	18	-	-	PUNCT
gs-4428	69	19	line	line	NOUN
gs-4428	69	20	agents	agent	NOUN
gs-4428	69	21	and	and	CCONJ
gs-4428	69	22	that	that	DET
gs-4428	69	23	treatment	treatment	NOUN
gs-4428	69	24	eligibility	eligibility	NOUN
gs-4428	69	25	assessment	assessment	NOUN
gs-4428	69	26	often	often	ADV
gs-4428	69	27	relies	rely	VERB
gs-4428	69	28	on	on	ADP
gs-4428	69	29	hbv	hbv	NOUN
gs-4428	69	30	dna	dna	PROPN
gs-4428	69	31	quantification	quantification	NOUN
gs-4428	69	32	and	and	CCONJ
gs-4428	69	33	fibrosis	fibrosis	NOUN
gs-4428	69	34	staging	stage	VERB
gs-4428	69	35	by	by	ADP
gs-4428	69	36	transient	transient	ADJ
gs-4428	69	37	elastography	elastography	NOUN
gs-4428	69	38	or	or	CCONJ
gs-4428	69	39	biochemical	biochemical	ADJ
gs-4428	69	40	indices	index	NOUN
gs-4428	69	41	(	(	PUNCT
gs-4428	69	42	apri	apri	NOUN
gs-4428	69	43	/	/	SYM
gs-4428	69	44	fib-4	fib-4	NUM
gs-4428	69	45	)	)	PUNCT
gs-4428	69	46	.	.	PUNCT
gs-4428	70	1	however	however	ADV
gs-4428	70	2	,	,	PUNCT
gs-4428	70	3	population	population	NOUN
gs-4428	70	4	-	-	PUNCT
gs-4428	70	5	level	level	NOUN
gs-4428	70	6	data	datum	NOUN
gs-4428	70	7	on	on	ADP
gs-4428	70	8	these	these	DET
gs-4428	70	9	clinical	clinical	ADJ
gs-4428	70	10	parameters	parameter	NOUN
gs-4428	70	11	remain	remain	VERB
gs-4428	70	12	scarce	scarce	ADJ
gs-4428	70	13	.	.	PUNCT
gs-4428	71	1	these	these	DET
gs-4428	71	2	gaps	gap	NOUN
gs-4428	71	3	underscore	underscore	VERB
gs-4428	71	4	the	the	DET
gs-4428	71	5	need	need	NOUN
gs-4428	71	6	to	to	PART
gs-4428	71	7	expand	expand	VERB
gs-4428	71	8	routine	routine	ADJ
gs-4428	71	9	adult	adult	NOUN
gs-4428	71	10	screening	screening	NOUN
gs-4428	71	11	beyond	beyond	ADP
gs-4428	71	12	blood	blood	NOUN
gs-4428	71	13	donors	donor	NOUN
gs-4428	71	14	and	and	CCONJ
gs-4428	71	15	pregnant	pregnant	ADJ
gs-4428	71	16	women	woman	NOUN
gs-4428	71	17	and	and	CCONJ
gs-4428	71	18	to	to	PART
gs-4428	71	19	strengthen	strengthen	VERB
gs-4428	71	20	linkage	linkage	NOUN
gs-4428	71	21	-	-	PUNCT
gs-4428	71	22	to	to	ADP
gs-4428	71	23	-	-	PUNCT
gs-4428	71	24	care	care	NOUN
gs-4428	71	25	systems	system	NOUN
gs-4428	71	26	integrated	integrate	VERB
gs-4428	71	27	with	with	ADP
gs-4428	71	28	existing	exist	VERB
gs-4428	71	29	hepatitis	hepatitis	NOUN
gs-4428	71	30	c	c	NOUN
gs-4428	71	31	elimination	elimination	NOUN
gs-4428	71	32	infrastructure	infrastructure	NOUN
gs-4428	71	33	(	(	PUNCT
gs-4428	71	34	cghe	cghe	NOUN
gs-4428	71	35	2025	2025	NUM
gs-4428	71	36	;	;	PUNCT
gs-4428	71	37	world	world	NOUN
gs-4428	71	38	health	health	NOUN
gs-4428	71	39	organization	organization	NOUN
gs-4428	71	40	2024	2024	NUM
gs-4428	71	41	)	)	PUNCT
gs-4428	71	42	.	.	PUNCT
gs-4428	72	1	equity	equity	NOUN
gs-4428	72	2	and	and	CCONJ
gs-4428	72	3	programmatic	programmatic	ADJ
gs-4428	72	4	gaps	gap	NOUN
gs-4428	72	5	across	across	ADP
gs-4428	72	6	the	the	DET
gs-4428	72	7	prevention	prevention	NOUN
gs-4428	72	8	-	-	PUNCT
gs-4428	72	9	to	to	ADP
gs-4428	72	10	-	-	PUNCT
gs-4428	72	11	care	care	NOUN
gs-4428	72	12	cascade	cascade	NOUN
gs-4428	72	13	,	,	PUNCT
gs-4428	72	14	evidence	evidence	NOUN
gs-4428	72	15	on	on	ADP
gs-4428	72	16	inequities	inequity	NOUN
gs-4428	72	17	by	by	ADP
gs-4428	72	18	sex	sex	NOUN
gs-4428	72	19	,	,	PUNCT
gs-4428	72	20	age	age	NOUN
gs-4428	72	21	,	,	PUNCT
gs-4428	72	22	region	region	NOUN
gs-4428	72	23	,	,	PUNCT
gs-4428	72	24	and	and	CCONJ
gs-4428	72	25	population	population	NOUN
gs-4428	72	26	group	group	NOUN
gs-4428	72	27	remains	remain	VERB
gs-4428	72	28	limited	limited	ADJ
gs-4428	72	29	.	.	PUNCT
gs-4428	73	1	the	the	DET
gs-4428	73	2	2015	2015	NUM
gs-4428	73	3	and	and	CCONJ
gs-4428	73	4	2021	2021	NUM
gs-4428	73	5	serosurveys	serosurvey	NOUN
gs-4428	73	6	found	find	VERB
gs-4428	73	7	no	no	DET
gs-4428	73	8	major	major	ADJ
gs-4428	73	9	sex	sex	NOUN
gs-4428	73	10	differences	difference	NOUN
gs-4428	73	11	in	in	ADP
gs-4428	73	12	hbsag	hbsag	ADJ
gs-4428	73	13	prevalence	prevalence	NOUN
gs-4428	73	14	,	,	PUNCT
gs-4428	73	15	but	but	CCONJ
gs-4428	73	16	higher	high	ADJ
gs-4428	73	17	anti	anti	ADJ
gs-4428	73	18	-	-	ADJ
gs-4428	73	19	hbc	hbc	ADJ
gs-4428	73	20	positivity	positivity	NOUN
gs-4428	73	21	was	be	AUX
gs-4428	73	22	noted	note	VERB
gs-4428	73	23	among	among	ADP
gs-4428	73	24	older	old	ADJ
gs-4428	73	25	age	age	NOUN
gs-4428	73	26	groups	group	NOUN
gs-4428	73	27	(	(	PUNCT
gs-4428	73	28	kasradze	kasradze	PROPN
gs-4428	73	29	et	et	PROPN
gs-4428	73	30	al	al	PROPN
gs-4428	73	31	.	.	PROPN
gs-4428	73	32	2020	2020	NUM
gs-4428	73	33	;	;	PUNCT
gs-4428	73	34	khetsuriani	khetsuriani	PROPN
gs-4428	73	35	et	et	PROPN
gs-4428	73	36	al	al	PROPN
gs-4428	73	37	.	.	PROPN
gs-4428	73	38	2023	2023	NUM
gs-4428	73	39	)	)	PUNCT
gs-4428	73	40	.	.	PUNCT
gs-4428	74	1	data	datum	NOUN
gs-4428	74	2	on	on	ADP
gs-4428	74	3	key	key	ADJ
gs-4428	74	4	populations	population	NOUN
gs-4428	74	5	such	such	ADJ
gs-4428	74	6	as	as	ADP
gs-4428	74	7	people	people	NOUN
gs-4428	74	8	who	who	PRON
gs-4428	74	9	inject	inject	VERB
gs-4428	74	10	drugs	drug	NOUN
gs-4428	74	11	,	,	PUNCT
gs-4428	74	12	migrant	migrant	ADJ
gs-4428	74	13	workers	worker	NOUN
gs-4428	74	14	,	,	PUNCT
gs-4428	74	15	and	and	CCONJ
gs-4428	74	16	health	health	NOUN
gs-4428	74	17	-	-	PUNCT
gs-4428	74	18	care	care	NOUN
gs-4428	74	19	workers	worker	NOUN
gs-4428	74	20	are	be	AUX
gs-4428	74	21	scarce	scarce	ADJ
gs-4428	74	22	and	and	CCONJ
gs-4428	74	23	fragmentary	fragmentary	ADJ
gs-4428	74	24	,	,	PUNCT
gs-4428	74	25	mostly	mostly	ADV
gs-4428	74	26	derived	derive	VERB
gs-4428	74	27	from	from	ADP
gs-4428	74	28	hcv	hcv	NOUN
gs-4428	74	29	-	-	PUNCT
gs-4428	74	30	focused	focused	ADJ
gs-4428	74	31	studies	study	NOUN
gs-4428	74	32	.	.	PUNCT
gs-4428	75	1	geographic	geographic	ADJ
gs-4428	75	2	equity	equity	NOUN
gs-4428	75	3	challenges	challenge	NOUN
gs-4428	75	4	persist	persist	VERB
gs-4428	75	5	in	in	ADP
gs-4428	75	6	ensuring	ensure	VERB
gs-4428	75	7	timely	timely	ADJ
gs-4428	75	8	birth	birth	NOUN
gs-4428	75	9	-	-	PUNCT
gs-4428	75	10	dose	dose	NOUN
gs-4428	75	11	administration	administration	NOUN
gs-4428	75	12	and	and	CCONJ
gs-4428	75	13	consistent	consistent	ADJ
gs-4428	75	14	antenatal	antenatal	NOUN
gs-4428	75	15	screening	screen	VERB
gs-4428	75	16	coverage	coverage	NOUN
gs-4428	75	17	in	in	ADP
gs-4428	75	18	rural	rural	ADJ
gs-4428	75	19	regions	region	NOUN
gs-4428	75	20	.	.	PUNCT
gs-4428	76	1	at	at	ADP
gs-4428	76	2	the	the	DET
gs-4428	76	3	programmatic	programmatic	ADJ
gs-4428	76	4	level	level	NOUN
gs-4428	76	5	,	,	PUNCT
gs-4428	76	6	the	the	DET
gs-4428	76	7	absence	absence	NOUN
gs-4428	76	8	of	of	ADP
gs-4428	76	9	a	a	DET
gs-4428	76	10	national	national	ADJ
gs-4428	76	11	treatment	treatment	NOUN
gs-4428	76	12	registry	registry	NOUN
gs-4428	76	13	and	and	CCONJ
gs-4428	76	14	limited	limited	ADJ
gs-4428	76	15	interoperability	interoperability	NOUN
gs-4428	76	16	between	between	ADP
gs-4428	76	17	hepatitis	hepatitis	NOUN
gs-4428	76	18	and	and	CCONJ
gs-4428	76	19	human	human	ADJ
gs-4428	76	20	immunodeficiency	immunodeficiency	NOUN
gs-4428	76	21	virus	virus	NOUN
gs-4428	76	22	(	(	PUNCT
gs-4428	76	23	hiv	hiv	PROPN
gs-4428	76	24	)	)	PUNCT
gs-4428	76	25	information	information	NOUN
gs-4428	76	26	georgian	georgian	NOUN
gs-4428	76	27	scientists/	scientists/	NUM
gs-4428	76	28	.	.	PUNCT
gs-4428	77	1	7	7	NUM
gs-4428	77	2	n	n	DET
gs-4428	77	3	4	4	NUM
gs-4428	77	4	,	,	PUNCT
gs-4428	77	5	2025	2025	NUM
gs-4428	77	6	626	626	NUM
gs-4428	77	7	systems	system	NOUN
gs-4428	77	8	impede	impede	VERB
gs-4428	77	9	comprehensive	comprehensive	ADJ
gs-4428	77	10	equity	equity	NOUN
gs-4428	77	11	monitoring	monitoring	NOUN
gs-4428	77	12	(	(	PUNCT
gs-4428	77	13	coalition	coalition	NOUN
gs-4428	77	14	for	for	ADP
gs-4428	77	15	global	global	ADJ
gs-4428	77	16	hepatitis	hepatitis	NOUN
gs-4428	77	17	elimination	elimination	NOUN
gs-4428	77	18	2025	2025	NUM
gs-4428	77	19	;	;	PUNCT
gs-4428	77	20	world	world	NOUN
gs-4428	77	21	health	health	NOUN
gs-4428	77	22	organization	organization	NOUN
gs-4428	77	23	2024	2024	NUM
gs-4428	77	24	)	)	PUNCT
gs-4428	77	25	.	.	PUNCT
gs-4428	78	1	overall	overall	ADV
gs-4428	78	2	,	,	PUNCT
gs-4428	78	3	georgia	georgia	PROPN
gs-4428	78	4	’s	’s	PART
gs-4428	78	5	achievements	achievement	NOUN
gs-4428	78	6	in	in	ADP
gs-4428	78	7	pediatric	pediatric	ADJ
gs-4428	78	8	control	control	NOUN
gs-4428	78	9	contrast	contrast	NOUN
gs-4428	78	10	with	with	ADP
gs-4428	78	11	uneven	uneven	ADJ
gs-4428	78	12	progress	progress	NOUN
gs-4428	78	13	in	in	ADP
gs-4428	78	14	adult	adult	NOUN
gs-4428	78	15	testing	testing	NOUN
gs-4428	78	16	and	and	CCONJ
gs-4428	78	17	treatment	treatment	NOUN
gs-4428	78	18	,	,	PUNCT
gs-4428	78	19	emphasizing	emphasize	VERB
gs-4428	78	20	the	the	DET
gs-4428	78	21	importance	importance	NOUN
gs-4428	78	22	of	of	ADP
gs-4428	78	23	integrated	integrated	ADJ
gs-4428	78	24	and	and	CCONJ
gs-4428	78	25	equitable	equitable	ADJ
gs-4428	78	26	health	health	NOUN
gs-4428	78	27	system	system	NOUN
gs-4428	78	28	approaches	approach	NOUN
gs-4428	78	29	.	.	PUNCT
gs-4428	79	1	discussion	discussion	NOUN
gs-4428	79	2	this	this	DET
gs-4428	79	3	scoping	scoping	NOUN
gs-4428	79	4	review	review	NOUN
gs-4428	79	5	synthesized	synthesize	VERB
gs-4428	79	6	a	a	DET
gs-4428	79	7	decade	decade	NOUN
gs-4428	79	8	of	of	ADP
gs-4428	79	9	hepatitis	hepatitis	NOUN
gs-4428	79	10	b	b	PROPN
gs-4428	79	11	evidence	evidence	NOUN
gs-4428	79	12	in	in	ADP
gs-4428	79	13	georgia	georgia	PROPN
gs-4428	79	14	(	(	PUNCT
gs-4428	79	15	2015–2025	2015–2025	NUM
gs-4428	79	16	)	)	PUNCT
gs-4428	79	17	,	,	PUNCT
gs-4428	79	18	mapping	map	VERB
gs-4428	79	19	epidemiologic	epidemiologic	ADJ
gs-4428	79	20	trends	trend	NOUN
gs-4428	79	21	,	,	PUNCT
gs-4428	79	22	prevention	prevention	NOUN
gs-4428	79	23	coverage	coverage	NOUN
gs-4428	79	24	,	,	PUNCT
gs-4428	79	25	testing	testing	NOUN
gs-4428	79	26	-	-	PUNCT
gs-4428	79	27	treatment	treatment	NOUN
gs-4428	79	28	performance	performance	NOUN
gs-4428	79	29	,	,	PUNCT
gs-4428	79	30	and	and	CCONJ
gs-4428	79	31	equity	equity	NOUN
gs-4428	79	32	.	.	PUNCT
gs-4428	80	1	the	the	DET
gs-4428	80	2	findings	finding	NOUN
gs-4428	80	3	show	show	VERB
gs-4428	80	4	remarkable	remarkable	ADJ
gs-4428	80	5	achievements	achievement	NOUN
gs-4428	80	6	in	in	ADP
gs-4428	80	7	childhood	childhood	NOUN
gs-4428	80	8	hbv	hbv	NOUN
gs-4428	80	9	control	control	NOUN
gs-4428	80	10	through	through	ADP
gs-4428	80	11	sustained	sustained	ADJ
gs-4428	80	12	vaccination	vaccination	NOUN
gs-4428	80	13	and	and	CCONJ
gs-4428	80	14	pmtct	pmtct	NOUN
gs-4428	80	15	,	,	PUNCT
gs-4428	80	16	contrasted	contrast	VERB
gs-4428	80	17	with	with	ADP
gs-4428	80	18	slower	slow	ADJ
gs-4428	80	19	progress	progress	NOUN
gs-4428	80	20	in	in	ADP
gs-4428	80	21	adult	adult	NOUN
gs-4428	80	22	diagnosis	diagnosis	NOUN
gs-4428	80	23	and	and	CCONJ
gs-4428	80	24	treatment	treatment	NOUN
gs-4428	80	25	.	.	PUNCT
gs-4428	81	1	these	these	DET
gs-4428	81	2	results	result	NOUN
gs-4428	81	3	reflect	reflect	VERB
gs-4428	81	4	georgia	georgia	PROPN
gs-4428	81	5	’s	’s	PART
gs-4428	81	6	transition	transition	NOUN
gs-4428	81	7	from	from	ADP
gs-4428	81	8	a	a	DET
gs-4428	81	9	vaccination	vaccination	NOUN
gs-4428	81	10	-	-	PUNCT
gs-4428	81	11	driven	drive	VERB
gs-4428	81	12	prevention	prevention	NOUN
gs-4428	81	13	phase	phase	NOUN
gs-4428	81	14	toward	toward	ADP
gs-4428	81	15	the	the	DET
gs-4428	81	16	more	more	ADV
gs-4428	81	17	complex	complex	ADJ
gs-4428	81	18	challenge	challenge	NOUN
gs-4428	81	19	of	of	ADP
gs-4428	81	20	chronic	chronic	ADJ
gs-4428	81	21	infection	infection	NOUN
gs-4428	81	22	management	management	NOUN
gs-4428	81	23	among	among	ADP
gs-4428	81	24	adults	adult	NOUN
gs-4428	81	25	.	.	PUNCT
gs-4428	82	1	comparison	comparison	NOUN
gs-4428	82	2	with	with	ADP
gs-4428	82	3	regional	regional	ADJ
gs-4428	82	4	and	and	CCONJ
gs-4428	82	5	global	global	ADJ
gs-4428	82	6	evidence	evidence	NOUN
gs-4428	82	7	georgia	georgia	PROPN
gs-4428	82	8	’s	’s	PART
gs-4428	82	9	hbsag	hbsag	ADJ
gs-4428	82	10	prevalence	prevalence	NOUN
gs-4428	82	11	of	of	ADP
gs-4428	82	12	2.7	2.7	NUM
gs-4428	82	13	%	%	NOUN
gs-4428	82	14	among	among	ADP
gs-4428	82	15	adults	adult	NOUN
gs-4428	82	16	aligns	align	VERB
gs-4428	82	17	with	with	ADP
gs-4428	82	18	the	the	DET
gs-4428	82	19	lower	low	ADJ
gs-4428	82	20	-	-	PUNCT
gs-4428	82	21	intermediate	intermediate	ADJ
gs-4428	82	22	range	range	NOUN
gs-4428	82	23	for	for	ADP
gs-4428	82	24	the	the	DET
gs-4428	82	25	who	who	PRON
gs-4428	82	26	european	european	PROPN
gs-4428	82	27	region	region	NOUN
gs-4428	82	28	,	,	PUNCT
gs-4428	82	29	where	where	SCONJ
gs-4428	82	30	the	the	DET
gs-4428	82	31	median	median	ADJ
gs-4428	82	32	adult	adult	NOUN
gs-4428	82	33	prevalence	prevalence	NOUN
gs-4428	82	34	is	be	AUX
gs-4428	82	35	approximately	approximately	ADV
gs-4428	82	36	1.6	1.6	NUM
gs-4428	82	37	%	%	NOUN
gs-4428	82	38	(	(	PUNCT
gs-4428	82	39	world	world	NOUN
gs-4428	82	40	health	health	NOUN
gs-4428	82	41	organization	organization	NOUN
gs-4428	82	42	2024	2024	NUM
gs-4428	82	43	)	)	PUNCT
gs-4428	82	44	.	.	PUNCT
gs-4428	83	1	the	the	DET
gs-4428	83	2	near	near	ADV
gs-4428	83	3	-	-	PUNCT
gs-4428	83	4	zero	zero	NUM
gs-4428	83	5	hbsag	hbsag	ADJ
gs-4428	83	6	prevalence	prevalence	NOUN
gs-4428	83	7	among	among	ADP
gs-4428	83	8	children	child	NOUN
gs-4428	83	9	(	(	PUNCT
gs-4428	83	10	0.03	0.03	NUM
gs-4428	83	11	%	%	NOUN
gs-4428	83	12	)	)	PUNCT
gs-4428	83	13	places	place	VERB
gs-4428	83	14	georgia	georgia	PROPN
gs-4428	83	15	among	among	ADP
gs-4428	83	16	a	a	DET
gs-4428	83	17	small	small	ADJ
gs-4428	83	18	group	group	NOUN
gs-4428	83	19	of	of	ADP
gs-4428	83	20	countries	country	NOUN
gs-4428	83	21	that	that	PRON
gs-4428	83	22	have	have	AUX
gs-4428	83	23	achieved	achieve	VERB
gs-4428	83	24	the	the	PRON
gs-4428	83	25	who	who	PRON
gs-4428	83	26	target	target	VERB
gs-4428	83	27	of	of	ADP
gs-4428	83	28	0.1	0.1	NUM
gs-4428	83	29	%	%	NOUN
gs-4428	83	30	prevalence	prevalence	NOUN
gs-4428	83	31	in	in	ADP
gs-4428	83	32	children	child	NOUN
gs-4428	83	33	under	under	ADP
gs-4428	83	34	5	5	NUM
gs-4428	83	35	years	year	NOUN
gs-4428	83	36	.	.	PUNCT
gs-4428	84	1	this	this	DET
gs-4428	84	2	success	success	NOUN
gs-4428	84	3	parallels	parallel	VERB
gs-4428	84	4	reports	report	NOUN
gs-4428	84	5	from	from	ADP
gs-4428	84	6	belarus	belarus	PROPN
gs-4428	84	7	and	and	CCONJ
gs-4428	84	8	kazakhstan	kazakhstan	PROPN
gs-4428	84	9	,	,	PUNCT
gs-4428	84	10	where	where	SCONJ
gs-4428	84	11	long	long	ADV
gs-4428	84	12	-	-	PUNCT
gs-4428	84	13	standing	stand	VERB
gs-4428	84	14	high	high	ADJ
gs-4428	84	15	coverage	coverage	NOUN
gs-4428	84	16	of	of	ADP
gs-4428	84	17	the	the	DET
gs-4428	84	18	hepatitis	hepatitis	PROPN
gs-4428	84	19	b	b	PROPN
gs-4428	84	20	birth	birth	NOUN
gs-4428	84	21	dose	dose	NOUN
gs-4428	84	22	and	and	CCONJ
gs-4428	84	23	three	three	NUM
gs-4428	84	24	-	-	PUNCT
gs-4428	84	25	dose	dose	NOUN
gs-4428	84	26	series	series	NOUN
gs-4428	84	27	have	have	AUX
gs-4428	84	28	produced	produce	VERB
gs-4428	84	29	similarly	similarly	ADV
gs-4428	84	30	low	low	ADJ
gs-4428	84	31	pediatric	pediatric	ADJ
gs-4428	84	32	prevalence	prevalence	NOUN
gs-4428	84	33	(	(	PUNCT
gs-4428	84	34	world	world	NOUN
gs-4428	84	35	health	health	NOUN
gs-4428	84	36	organization	organization	NOUN
gs-4428	84	37	2024	2024	NUM
gs-4428	84	38	)	)	PUNCT
gs-4428	84	39	.	.	PUNCT
gs-4428	85	1	the	the	DET
gs-4428	85	2	persistence	persistence	NOUN
gs-4428	85	3	of	of	ADP
gs-4428	85	4	infection	infection	NOUN
gs-4428	85	5	among	among	ADP
gs-4428	85	6	adults	adult	NOUN
gs-4428	85	7	,	,	PUNCT
gs-4428	85	8	however	however	ADV
gs-4428	85	9	,	,	PUNCT
gs-4428	85	10	mirrors	mirror	NOUN
gs-4428	85	11	regional	regional	ADJ
gs-4428	85	12	patterns	pattern	NOUN
gs-4428	85	13	where	where	SCONJ
gs-4428	85	14	populations	population	NOUN
gs-4428	85	15	born	bear	VERB
gs-4428	85	16	before	before	ADP
gs-4428	85	17	universal	universal	ADJ
gs-4428	85	18	vaccination	vaccination	NOUN
gs-4428	85	19	remain	remain	VERB
gs-4428	85	20	reservoirs	reservoir	NOUN
gs-4428	85	21	of	of	ADP
gs-4428	85	22	chronic	chronic	ADJ
gs-4428	85	23	hbv	hbv	NOUN
gs-4428	85	24	(	(	PUNCT
gs-4428	85	25	polaris	polaris	NOUN
gs-4428	85	26	observatory	observatory	ADJ
gs-4428	85	27	collaborators	collaborator	NOUN
gs-4428	85	28	2023	2023	NUM
gs-4428	85	29	)	)	PUNCT
gs-4428	85	30	.	.	PUNCT
gs-4428	86	1	the	the	DET
gs-4428	86	2	limited	limited	ADJ
gs-4428	86	3	diagnosis	diagnosis	NOUN
gs-4428	86	4	(	(	PUNCT
gs-4428	86	5	25	25	NUM
gs-4428	86	6	%	%	NOUN
gs-4428	86	7	)	)	PUNCT
gs-4428	86	8	and	and	CCONJ
gs-4428	86	9	treatment	treatment	NOUN
gs-4428	86	10	(	(	PUNCT
gs-4428	86	11	5	5	NUM
gs-4428	86	12	%	%	NOUN
gs-4428	86	13	)	)	PUNCT
gs-4428	86	14	coverage	coverage	NOUN
gs-4428	86	15	documented	document	VERB
gs-4428	86	16	by	by	ADP
gs-4428	86	17	national	national	ADJ
gs-4428	86	18	and	and	CCONJ
gs-4428	86	19	partner	partner	NOUN
gs-4428	86	20	reports	report	NOUN
gs-4428	86	21	(	(	PUNCT
gs-4428	86	22	tohme	tohme	NOUN
gs-4428	86	23	et	et	PROPN
gs-4428	86	24	al	al	PROPN
gs-4428	86	25	.	.	PROPN
gs-4428	86	26	2024	2024	NUM
gs-4428	86	27	;	;	PUNCT
gs-4428	86	28	coalition	coalition	NOUN
gs-4428	86	29	for	for	ADP
gs-4428	86	30	global	global	ADJ
gs-4428	86	31	hepatitis	hepatitis	NOUN
gs-4428	86	32	elimination	elimination	NOUN
gs-4428	86	33	2025	2025	NUM
gs-4428	86	34	)	)	PUNCT
gs-4428	86	35	highlight	highlight	VERB
gs-4428	86	36	a	a	DET
gs-4428	86	37	continuing	continue	VERB
gs-4428	86	38	gap	gap	NOUN
gs-4428	86	39	across	across	ADP
gs-4428	86	40	the	the	DET
gs-4428	86	41	who	who	PRON
gs-4428	86	42	“	"	PUNCT
gs-4428	86	43	90	90	NUM
gs-4428	86	44	-	-	PUNCT
gs-4428	86	45	80	80	NUM
gs-4428	86	46	-	-	PUNCT
gs-4428	86	47	65	65	NUM
gs-4428	86	48	”	"	PUNCT
gs-4428	86	49	elimination	elimination	NOUN
gs-4428	86	50	cascade	cascade	NOUN
gs-4428	86	51	.	.	PUNCT
gs-4428	87	1	these	these	DET
gs-4428	87	2	values	value	NOUN
gs-4428	87	3	are	be	AUX
gs-4428	87	4	comparable	comparable	ADJ
gs-4428	87	5	to	to	ADP
gs-4428	87	6	or	or	CCONJ
gs-4428	87	7	slightly	slightly	ADV
gs-4428	87	8	below	below	ADP
gs-4428	87	9	those	those	PRON
gs-4428	87	10	reported	report	VERB
gs-4428	87	11	for	for	ADP
gs-4428	87	12	other	other	ADJ
gs-4428	87	13	upper	upper	ADJ
gs-4428	87	14	-	-	PUNCT
gs-4428	87	15	middle	middle	ADJ
gs-4428	87	16	-	-	PUNCT
gs-4428	87	17	income	income	NOUN
gs-4428	87	18	european	european	ADJ
gs-4428	87	19	countries	country	NOUN
gs-4428	87	20	,	,	PUNCT
gs-4428	87	21	indicating	indicate	VERB
gs-4428	87	22	the	the	DET
gs-4428	87	23	need	need	NOUN
gs-4428	87	24	for	for	ADP
gs-4428	87	25	scale	scale	NOUN
gs-4428	87	26	-	-	PUNCT
gs-4428	87	27	up	up	NOUN
gs-4428	87	28	of	of	ADP
gs-4428	87	29	testing	testing	NOUN
gs-4428	87	30	within	within	ADP
gs-4428	87	31	primary	primary	ADJ
gs-4428	87	32	-	-	PUNCT
gs-4428	87	33	care	care	NOUN
gs-4428	87	34	and	and	CCONJ
gs-4428	87	35	harm	harm	NOUN
gs-4428	87	36	-	-	PUNCT
gs-4428	87	37	reduction	reduction	NOUN
gs-4428	87	38	services	service	NOUN
gs-4428	87	39	.	.	PUNCT
gs-4428	88	1	interpretation	interpretation	NOUN
gs-4428	88	2	of	of	ADP
gs-4428	88	3	progress	progress	NOUN
gs-4428	88	4	and	and	CCONJ
gs-4428	88	5	barriers	barrier	VERB
gs-4428	88	6	high	high	ADJ
gs-4428	88	7	vaccine	vaccine	NOUN
gs-4428	88	8	coverage	coverage	NOUN
gs-4428	88	9	and	and	CCONJ
gs-4428	88	10	pmtct	pmtct	NOUN
gs-4428	88	11	integration	integration	NOUN
gs-4428	88	12	have	have	AUX
gs-4428	88	13	nearly	nearly	ADV
gs-4428	88	14	interrupted	interrupt	VERB
gs-4428	88	15	vertical	vertical	ADJ
gs-4428	88	16	transmission	transmission	NOUN
gs-4428	88	17	,	,	PUNCT
gs-4428	88	18	supported	support	VERB
gs-4428	88	19	by	by	ADP
gs-4428	88	20	strong	strong	ADJ
gs-4428	88	21	cold	cold	ADJ
gs-4428	88	22	-	-	PUNCT
gs-4428	88	23	chain	chain	NOUN
gs-4428	88	24	and	and	CCONJ
gs-4428	88	25	maternal	maternal	ADJ
gs-4428	88	26	-	-	PUNCT
gs-4428	88	27	child	child	NOUN
gs-4428	88	28	health	health	NOUN
gs-4428	88	29	infrastructure	infrastructure	NOUN
gs-4428	88	30	.	.	PUNCT
gs-4428	89	1	in	in	ADP
gs-4428	89	2	contrast	contrast	NOUN
gs-4428	89	3	,	,	PUNCT
gs-4428	89	4	horizontal	horizontal	ADJ
gs-4428	89	5	transmission	transmission	NOUN
gs-4428	89	6	in	in	ADP
gs-4428	89	7	adulthood	adulthood	NOUN
gs-4428	89	8	remains	remain	VERB
gs-4428	89	9	under	under	ADV
gs-4428	89	10	-	-	PUNCT
gs-4428	89	11	addressed	address	VERB
gs-4428	89	12	.	.	PUNCT
gs-4428	90	1	barriers	barrier	NOUN
gs-4428	90	2	include	include	VERB
gs-4428	90	3	the	the	DET
gs-4428	90	4	absence	absence	NOUN
gs-4428	90	5	of	of	ADP
gs-4428	90	6	a	a	DET
gs-4428	90	7	national	national	ADJ
gs-4428	90	8	hbv	hbv	NOUN
gs-4428	90	9	registry	registry	NOUN
gs-4428	90	10	,	,	PUNCT
gs-4428	90	11	limited	limited	ADJ
gs-4428	90	12	availability	availability	NOUN
gs-4428	90	13	of	of	ADP
gs-4428	90	14	hbv	hbv	NOUN
gs-4428	90	15	dna	dna	PROPN
gs-4428	90	16	testing	testing	NOUN
gs-4428	90	17	in	in	ADP
gs-4428	90	18	peripheral	peripheral	ADJ
gs-4428	90	19	laboratories	laboratory	NOUN
gs-4428	90	20	,	,	PUNCT
gs-4428	90	21	and	and	CCONJ
gs-4428	90	22	low	low	ADJ
gs-4428	90	23	awareness	awareness	NOUN
gs-4428	90	24	among	among	ADP
gs-4428	90	25	both	both	DET
gs-4428	90	26	clinicians	clinician	NOUN
gs-4428	90	27	and	and	CCONJ
gs-4428	90	28	the	the	DET
gs-4428	90	29	public	public	NOUN
gs-4428	90	30	about	about	ADP
gs-4428	90	31	antiviral	antiviral	ADJ
gs-4428	90	32	eligibility	eligibility	NOUN
gs-4428	90	33	criteria	criterion	NOUN
gs-4428	90	34	.	.	PUNCT
gs-4428	91	1	fragmentation	fragmentation	NOUN
gs-4428	91	2	between	between	ADP
gs-4428	91	3	hepatitis	hepatitis	PROPN
gs-4428	91	4	,	,	PUNCT
gs-4428	91	5	hiv	hiv	PROPN
gs-4428	91	6	,	,	PUNCT
gs-4428	91	7	and	and	CCONJ
gs-4428	91	8	general	general	ADJ
gs-4428	91	9	-	-	PUNCT
gs-4428	91	10	practice	practice	NOUN
gs-4428	91	11	information	information	NOUN
gs-4428	91	12	systems	system	NOUN
gs-4428	91	13	further	far	ADV
gs-4428	91	14	constrains	constrain	VERB
gs-4428	91	15	surveillance	surveillance	NOUN
gs-4428	91	16	and	and	CCONJ
gs-4428	91	17	monitoring	monitoring	NOUN
gs-4428	91	18	of	of	ADP
gs-4428	91	19	treatment	treatment	NOUN
gs-4428	91	20	outcomes	outcome	NOUN
gs-4428	91	21	.	.	PUNCT
gs-4428	92	1	georgian	georgian	NOUN
gs-4428	92	2	scientists/	scientists/	NUM
gs-4428	92	3	.	.	PUNCT
gs-4428	93	1	7	7	NUM
gs-4428	93	2	n	n	DET
gs-4428	93	3	4	4	NUM
gs-4428	93	4	,	,	PUNCT
gs-4428	93	5	2025	2025	NUM
gs-4428	93	6	627	627	NUM
gs-4428	93	7	equity	equity	NOUN
gs-4428	93	8	considerations	consideration	NOUN
gs-4428	93	9	although	although	SCONJ
gs-4428	93	10	no	no	DET
gs-4428	93	11	major	major	ADJ
gs-4428	93	12	sex	sex	NOUN
gs-4428	93	13	differences	difference	NOUN
gs-4428	93	14	in	in	ADP
gs-4428	93	15	infection	infection	NOUN
gs-4428	93	16	prevalence	prevalence	NOUN
gs-4428	93	17	were	be	AUX
gs-4428	93	18	detected	detect	VERB
gs-4428	93	19	,	,	PUNCT
gs-4428	93	20	inequities	inequity	NOUN
gs-4428	93	21	persist	persist	VERB
gs-4428	93	22	by	by	ADP
gs-4428	93	23	geography	geography	NOUN
gs-4428	93	24	and	and	CCONJ
gs-4428	93	25	population	population	NOUN
gs-4428	93	26	group	group	NOUN
gs-4428	93	27	.	.	PUNCT
gs-4428	94	1	rural	rural	ADJ
gs-4428	94	2	regions	region	NOUN
gs-4428	94	3	experience	experience	VERB
gs-4428	94	4	lower	low	ADJ
gs-4428	94	5	birth	birth	NOUN
gs-4428	94	6	-	-	PUNCT
gs-4428	94	7	dose	dose	VERB
gs-4428	94	8	timeliness	timeliness	NOUN
gs-4428	94	9	and	and	CCONJ
gs-4428	94	10	less	less	ADJ
gs-4428	94	11	access	access	NOUN
gs-4428	94	12	to	to	ADP
gs-4428	94	13	confirmatory	confirmatory	NOUN
gs-4428	94	14	diagnostics	diagnostic	NOUN
gs-4428	94	15	,	,	PUNCT
gs-4428	94	16	while	while	SCONJ
gs-4428	94	17	data	datum	NOUN
gs-4428	94	18	for	for	ADP
gs-4428	94	19	key	key	ADJ
gs-4428	94	20	populations	population	NOUN
gs-4428	94	21	—	—	PUNCT
gs-4428	94	22	such	such	ADJ
gs-4428	94	23	as	as	ADP
gs-4428	94	24	people	people	NOUN
gs-4428	94	25	who	who	PRON
gs-4428	94	26	inject	inject	VERB
gs-4428	94	27	drugs	drug	NOUN
gs-4428	94	28	and	and	CCONJ
gs-4428	94	29	migrants	migrant	NOUN
gs-4428	94	30	are	be	AUX
gs-4428	94	31	scarce	scarce	ADJ
gs-4428	94	32	.	.	PUNCT
gs-4428	95	1	strengthening	strengthen	VERB
gs-4428	95	2	community	community	NOUN
gs-4428	95	3	outreach	outreach	NOUN
gs-4428	95	4	,	,	PUNCT
gs-4428	95	5	integrating	integrate	VERB
gs-4428	95	6	hbv	hbv	NOUN
gs-4428	95	7	screening	screening	NOUN
gs-4428	95	8	into	into	ADP
gs-4428	95	9	existing	exist	VERB
gs-4428	95	10	harm	harm	NOUN
gs-4428	95	11	-	-	PUNCT
gs-4428	95	12	reduction	reduction	NOUN
gs-4428	95	13	and	and	CCONJ
gs-4428	95	14	reproductive	reproductive	ADJ
gs-4428	95	15	-	-	PUNCT
gs-4428	95	16	health	health	NOUN
gs-4428	95	17	programs	program	NOUN
gs-4428	95	18	,	,	PUNCT
gs-4428	95	19	and	and	CCONJ
gs-4428	95	20	ensuring	ensure	VERB
gs-4428	95	21	equitable	equitable	ADJ
gs-4428	95	22	distribution	distribution	NOUN
gs-4428	95	23	of	of	ADP
gs-4428	95	24	diagnostics	diagnostic	NOUN
gs-4428	95	25	are	be	AUX
gs-4428	95	26	essential	essential	ADJ
gs-4428	95	27	to	to	PART
gs-4428	95	28	align	align	VERB
gs-4428	95	29	with	with	ADP
gs-4428	95	30	who	who	PRON
gs-4428	95	31	equity	equity	NOUN
gs-4428	95	32	principles	principle	NOUN
gs-4428	95	33	(	(	PUNCT
gs-4428	95	34	world	world	NOUN
gs-4428	95	35	health	health	NOUN
gs-4428	95	36	organization	organization	NOUN
gs-4428	95	37	2022a	2022a	NUM
gs-4428	95	38	,	,	PUNCT
gs-4428	95	39	2022b	2022b	NUM
gs-4428	95	40	)	)	PUNCT
gs-4428	95	41	.	.	PUNCT
gs-4428	96	1	policy	policy	NOUN
gs-4428	96	2	implications	implication	NOUN
gs-4428	96	3	the	the	DET
gs-4428	96	4	evidence	evidence	NOUN
gs-4428	96	5	supports	support	VERB
gs-4428	96	6	consolidating	consolidate	VERB
gs-4428	96	7	georgia	georgia	PROPN
gs-4428	96	8	’s	’s	PART
gs-4428	96	9	hepatitis	hepatitis	NOUN
gs-4428	96	10	-	-	PUNCT
gs-4428	96	11	control	control	NOUN
gs-4428	96	12	framework	framework	NOUN
gs-4428	96	13	into	into	ADP
gs-4428	96	14	a	a	DET
gs-4428	96	15	unified	unified	ADJ
gs-4428	96	16	hbv	hbv	NOUN
gs-4428	96	17	elimination	elimination	NOUN
gs-4428	96	18	program	program	NOUN
gs-4428	96	19	complementary	complementary	ADJ
gs-4428	96	20	to	to	ADP
gs-4428	96	21	its	its	PRON
gs-4428	96	22	existing	exist	VERB
gs-4428	96	23	hepatitis	hepatitis	NOUN
gs-4428	96	24	c	c	NOUN
gs-4428	96	25	initiative	initiative	NOUN
gs-4428	96	26	.	.	PUNCT
gs-4428	97	1	priority	priority	NOUN
gs-4428	97	2	actions	action	NOUN
gs-4428	97	3	include	include	VERB
gs-4428	97	4	:	:	PUNCT
gs-4428	97	5	1	1	X
gs-4428	97	6	.	.	X
gs-4428	97	7	establishing	establish	VERB
gs-4428	97	8	a	a	DET
gs-4428	97	9	national	national	ADJ
gs-4428	97	10	hbv	hbv	NOUN
gs-4428	97	11	treatment	treatment	NOUN
gs-4428	97	12	and	and	CCONJ
gs-4428	97	13	follow	follow	VERB
gs-4428	97	14	-	-	PUNCT
gs-4428	97	15	up	up	ADP
gs-4428	97	16	registry	registry	NOUN
gs-4428	97	17	;	;	PUNCT
gs-4428	97	18	2	2	X
gs-4428	97	19	.	.	X
gs-4428	97	20	expanding	expand	VERB
gs-4428	97	21	routine	routine	ADJ
gs-4428	97	22	adult	adult	NOUN
gs-4428	97	23	hbsag	hbsag	NOUN
gs-4428	97	24	screening	screen	VERB
gs-4428	97	25	through	through	ADP
gs-4428	97	26	primary	primary	ADJ
gs-4428	97	27	-	-	PUNCT
gs-4428	97	28	care	care	NOUN
gs-4428	97	29	,	,	PUNCT
gs-4428	97	30	occupational	occupational	ADJ
gs-4428	97	31	,	,	PUNCT
gs-4428	97	32	and	and	CCONJ
gs-4428	97	33	antenatal	antenatal	NOUN
gs-4428	97	34	platforms	platform	NOUN
gs-4428	97	35	;	;	PUNCT
gs-4428	97	36	3	3	X
gs-4428	97	37	.	.	X
gs-4428	97	38	decentralizing	decentralize	VERB
gs-4428	97	39	hbv	hbv	NOUN
gs-4428	97	40	dna	dna	PROPN
gs-4428	97	41	and	and	CCONJ
gs-4428	97	42	non	non	ADJ
gs-4428	97	43	-	-	ADJ
gs-4428	97	44	invasive	invasive	ADJ
gs-4428	97	45	fibrosis	fibrosis	NOUN
gs-4428	97	46	testing	testing	NOUN
gs-4428	97	47	(	(	PUNCT
gs-4428	97	48	e.g.	e.g.	ADV
gs-4428	97	49	,	,	PUNCT
gs-4428	97	50	transient	transient	ADJ
gs-4428	97	51	elastography	elastography	NOUN
gs-4428	97	52	)	)	PUNCT
gs-4428	97	53	to	to	ADP
gs-4428	97	54	regional	regional	ADJ
gs-4428	97	55	centers	center	NOUN
gs-4428	97	56	;	;	PUNCT
gs-4428	97	57	and	and	CCONJ
gs-4428	97	58	4	4	X
gs-4428	97	59	.	.	X
gs-4428	97	60	integrating	integrate	VERB
gs-4428	97	61	hbv	hbv	NOUN
gs-4428	97	62	indicators	indicator	NOUN
gs-4428	97	63	into	into	ADP
gs-4428	97	64	the	the	DET
gs-4428	97	65	national	national	ADJ
gs-4428	97	66	health	health	NOUN
gs-4428	97	67	-	-	PUNCT
gs-4428	97	68	information	information	NOUN
gs-4428	97	69	system	system	NOUN
gs-4428	97	70	to	to	PART
gs-4428	97	71	enable	enable	VERB
gs-4428	97	72	cascade	cascade	NOUN
gs-4428	97	73	monitoring	monitoring	NOUN
gs-4428	97	74	.	.	PUNCT
gs-4428	98	1	these	these	DET
gs-4428	98	2	steps	step	NOUN
gs-4428	98	3	would	would	AUX
gs-4428	98	4	accelerate	accelerate	VERB
gs-4428	98	5	progress	progress	NOUN
gs-4428	98	6	toward	toward	ADP
gs-4428	98	7	the	the	PRON
gs-4428	98	8	who	who	PRON
gs-4428	98	9	ghss	ghss	VERB
gs-4428	98	10	2030	2030	NUM
gs-4428	98	11	goals	goal	NOUN
gs-4428	98	12	of	of	ADP
gs-4428	98	13	90	90	NUM
gs-4428	98	14	%	%	NOUN
gs-4428	98	15	diagnosis	diagnosis	NOUN
gs-4428	98	16	,	,	PUNCT
gs-4428	98	17	80	80	NUM
gs-4428	98	18	%	%	NOUN
gs-4428	98	19	treatment	treatment	NOUN
gs-4428	98	20	,	,	PUNCT
gs-4428	98	21	and	and	CCONJ
gs-4428	98	22	65	65	NUM
gs-4428	98	23	%	%	NOUN
gs-4428	98	24	mortality	mortality	NOUN
gs-4428	98	25	reduction	reduction	NOUN
gs-4428	98	26	.	.	PUNCT
gs-4428	99	1	limitations	limitation	NOUN
gs-4428	99	2	as	as	ADP
gs-4428	99	3	a	a	DET
gs-4428	99	4	scoping	scoping	NOUN
gs-4428	99	5	rather	rather	ADV
gs-4428	99	6	than	than	ADP
gs-4428	99	7	systematic	systematic	ADJ
gs-4428	99	8	review	review	NOUN
gs-4428	100	1	,	,	PUNCT
gs-4428	100	2	this	this	DET
gs-4428	100	3	study	study	NOUN
gs-4428	100	4	did	do	AUX
gs-4428	100	5	not	not	PART
gs-4428	100	6	conduct	conduct	VERB
gs-4428	100	7	formal	formal	ADJ
gs-4428	100	8	quality	quality	NOUN
gs-4428	100	9	appraisal	appraisal	NOUN
gs-4428	100	10	or	or	CCONJ
gs-4428	100	11	quantitative	quantitative	ADJ
gs-4428	100	12	synthesis	synthesis	NOUN
gs-4428	100	13	.	.	PUNCT
gs-4428	101	1	grey	grey	ADJ
gs-4428	101	2	-	-	PUNCT
gs-4428	101	3	literature	literature	NOUN
gs-4428	101	4	sources	source	NOUN
gs-4428	101	5	,	,	PUNCT
gs-4428	101	6	although	although	SCONJ
gs-4428	101	7	authoritative	authoritative	ADJ
gs-4428	101	8	,	,	PUNCT
gs-4428	101	9	may	may	AUX
gs-4428	101	10	under	under	ADP
gs-4428	101	11	-	-	PUNCT
gs-4428	101	12	report	report	NOUN
gs-4428	101	13	recent	recent	ADJ
gs-4428	101	14	program	program	NOUN
gs-4428	101	15	data	datum	NOUN
gs-4428	101	16	or	or	CCONJ
gs-4428	101	17	duplicate	duplicate	VERB
gs-4428	101	18	information	information	NOUN
gs-4428	101	19	across	across	ADP
gs-4428	101	20	agencies	agency	NOUN
gs-4428	101	21	.	.	PUNCT
gs-4428	102	1	nevertheless	nevertheless	ADV
gs-4428	102	2	,	,	PUNCT
gs-4428	102	3	triangulating	triangulate	VERB
gs-4428	102	4	peer	peer	NOUN
gs-4428	102	5	-	-	PUNCT
gs-4428	102	6	reviewed	review	VERB
gs-4428	102	7	and	and	CCONJ
gs-4428	102	8	programmatic	programmatic	ADJ
gs-4428	102	9	evidence	evidence	NOUN
gs-4428	102	10	provides	provide	VERB
gs-4428	102	11	a	a	DET
gs-4428	102	12	reliable	reliable	ADJ
gs-4428	102	13	overview	overview	NOUN
gs-4428	102	14	of	of	ADP
gs-4428	102	15	georgia	georgia	PROPN
gs-4428	102	16	’s	’s	PART
gs-4428	102	17	hbv	hbv	NOUN
gs-4428	102	18	landscape	landscape	NOUN
gs-4428	102	19	and	and	CCONJ
gs-4428	102	20	identifies	identify	VERB
gs-4428	102	21	clear	clear	ADJ
gs-4428	102	22	data	datum	NOUN
gs-4428	102	23	and	and	CCONJ
gs-4428	102	24	policy	policy	NOUN
gs-4428	102	25	priorities	priority	NOUN
gs-4428	102	26	.	.	PUNCT
gs-4428	103	1	conclusion	conclusion	NOUN
gs-4428	103	2	georgia	georgia	PROPN
gs-4428	103	3	has	have	AUX
gs-4428	103	4	achieved	achieve	VERB
gs-4428	103	5	near	near	ADJ
gs-4428	103	6	-	-	PUNCT
gs-4428	103	7	elimination	elimination	NOUN
gs-4428	103	8	of	of	ADP
gs-4428	103	9	pediatric	pediatric	ADJ
gs-4428	103	10	hbv	hbv	NOUN
gs-4428	103	11	infection	infection	NOUN
gs-4428	103	12	through	through	ADP
gs-4428	103	13	strong	strong	ADJ
gs-4428	103	14	immunization	immunization	NOUN
gs-4428	103	15	and	and	CCONJ
gs-4428	103	16	pmtct	pmtct	NOUN
gs-4428	103	17	programs	program	NOUN
gs-4428	103	18	.	.	PUNCT
gs-4428	104	1	the	the	DET
gs-4428	104	2	next	next	ADJ
gs-4428	104	3	phase	phase	NOUN
gs-4428	104	4	of	of	ADP
gs-4428	104	5	elimination	elimination	NOUN
gs-4428	104	6	requires	require	VERB
gs-4428	104	7	closing	close	VERB
gs-4428	104	8	adult	adult	NOUN
gs-4428	104	9	testing	testing	NOUN
gs-4428	104	10	and	and	CCONJ
gs-4428	104	11	treatment	treatment	NOUN
gs-4428	104	12	gaps	gap	NOUN
gs-4428	104	13	,	,	PUNCT
gs-4428	104	14	integrating	integrate	VERB
gs-4428	104	15	equity	equity	NOUN
gs-4428	104	16	monitoring	monitoring	NOUN
gs-4428	104	17	,	,	PUNCT
gs-4428	104	18	and	and	CCONJ
gs-4428	104	19	strengthening	strengthen	VERB
gs-4428	104	20	national	national	ADJ
gs-4428	104	21	data	datum	NOUN
gs-4428	104	22	systems	system	NOUN
gs-4428	104	23	.	.	PUNCT
gs-4428	105	1	sustained	sustain	VERB
gs-4428	105	2	commitment	commitment	NOUN
gs-4428	105	3	and	and	CCONJ
gs-4428	105	4	regional	regional	ADJ
gs-4428	105	5	collaboration	collaboration	NOUN
gs-4428	105	6	will	will	AUX
gs-4428	105	7	be	be	AUX
gs-4428	105	8	essential	essential	ADJ
gs-4428	105	9	to	to	PART
gs-4428	105	10	reach	reach	VERB
gs-4428	105	11	the	the	DET
gs-4428	105	12	who	who	PRON
gs-4428	105	13	2030	2030	NUM
gs-4428	105	14	hepatitis	hepatitis	NOUN
gs-4428	105	15	b	b	NOUN
gs-4428	105	16	elimination	elimination	NOUN
gs-4428	105	17	targets	target	NOUN
gs-4428	105	18	.	.	PUNCT
gs-4428	106	1	georgian	georgian	NOUN
gs-4428	106	2	scientists/	scientists/	NUM
gs-4428	106	3	.	.	PUNCT
gs-4428	107	1	7	7	NUM
gs-4428	107	2	n	n	DET
gs-4428	107	3	4	4	NUM
gs-4428	107	4	,	,	PUNCT
gs-4428	107	5	2025	2025	NUM
gs-4428	107	6	628	628	NUM
gs-4428	107	7	table	table	NOUN
gs-4428	107	8	1	1	NUM
gs-4428	107	9	.	.	PUNCT
gs-4428	108	1	summary	summary	NOUN
gs-4428	108	2	of	of	ADP
gs-4428	108	3	hepatitis	hepatitis	PROPN
gs-4428	108	4	b	b	PROPN
gs-4428	108	5	indicators	indicator	NOUN
gs-4428	108	6	in	in	ADP
gs-4428	108	7	georgia	georgia	PROPN
gs-4428	108	8	,	,	PUNCT
gs-4428	108	9	2015–2025	2015–2025	NUM
gs-4428	108	10	domain	domain	NOUN
gs-4428	108	11	indicator	indicator	NOUN
gs-4428	108	12	2015	2015	NUM
gs-4428	108	13	baseline	baseline	VERB
gs-4428	108	14	2021–2025	2021–2025	NUM
gs-4428	108	15	value	value	NOUN
gs-4428	108	16	/	/	SYM
gs-4428	108	17	status	status	NOUN
gs-4428	108	18	source(s	source(s	NOUN
gs-4428	108	19	)	)	PUNCT
gs-4428	108	20	key	key	ADJ
gs-4428	108	21	comment	comment	NOUN
gs-4428	108	22	epidemiology	epidemiology	NOUN
gs-4428	108	23	hbsag	hbsag	ADJ
gs-4428	108	24	prevalence	prevalence	NOUN
gs-4428	108	25	,	,	PUNCT
gs-4428	108	26	adults	adult	NOUN
gs-4428	108	27	18	18	NUM
gs-4428	108	28	y	y	NUM
gs-4428	108	29	2.9	2.9	NUM
gs-4428	108	30	%	%	NOUN
gs-4428	108	31	2.7	2.7	NUM
gs-4428	108	32	%	%	NOUN
gs-4428	108	33	(	(	PUNCT
gs-4428	108	34	95	95	NUM
gs-4428	108	35	%	%	NOUN
gs-4428	108	36	ci	ci	NOUN
gs-4428	108	37	2.3	2.3	NUM
gs-4428	108	38	–	–	PUNCT
gs-4428	108	39	3.4	3.4	NUM
gs-4428	108	40	)	)	PUNCT
gs-4428	108	41	kasradze	kasradze	PROPN
gs-4428	108	42	et	et	PROPN
gs-4428	108	43	al	al	PROPN
gs-4428	108	44	.	.	PROPN
gs-4428	108	45	2020	2020	NUM
gs-4428	108	46	;	;	PUNCT
gs-4428	108	47	khetsuriani	khetsuriani	PROPN
gs-4428	108	48	et	et	PROPN
gs-4428	108	49	al	al	PROPN
gs-4428	108	50	.	.	PROPN
gs-4428	108	51	2023	2023	NUM
gs-4428	108	52	stable	stable	ADJ
gs-4428	108	53	intermediate	intermediate	ADJ
gs-4428	108	54	prevalence	prevalence	NOUN
gs-4428	108	55	hbsag	hbsag	ADJ
gs-4428	108	56	prevalence	prevalence	NOUN
gs-4428	108	57	,	,	PUNCT
gs-4428	108	58	children	child	NOUN
gs-4428	108	59	5–17	5–17	PROPN
gs-4428	108	60	y	y	PROPN
gs-4428	108	61	–	–	PUNCT
gs-4428	108	62	0.03	0.03	NUM
gs-4428	108	63	%	%	NOUN
gs-4428	108	64	(	(	PUNCT
gs-4428	108	65	95	95	NUM
gs-4428	108	66	%	%	NOUN
gs-4428	108	67	ci	ci	NOUN
gs-4428	108	68	0.0	0.0	NUM
gs-4428	108	69	–	–	PUNCT
gs-4428	108	70	0.19	0.19	NUM
gs-4428	108	71	)	)	PUNCT
gs-4428	108	72	khetsuriani	khetsuriani	NOUN
gs-4428	108	73	et	et	PROPN
gs-4428	108	74	al	al	PROPN
gs-4428	108	75	.	.	PROPN
gs-4428	108	76	2023	2023	NUM
gs-4428	108	77	near	near	ADP
gs-4428	108	78	-	-	PUNCT
gs-4428	108	79	elimination	elimination	NOUN
gs-4428	108	80	vaccination	vaccination	NOUN
gs-4428	108	81	/	/	SYM
gs-4428	108	82	pmtct	pmtct	NOUN
gs-4428	108	83	hepb	hepb	ADJ
gs-4428	108	84	-	-	PUNCT
gs-4428	108	85	bd	bd	NOUN
gs-4428	108	86	coverage	coverage	NOUN
gs-4428	108	87	93	93	NUM
gs-4428	108	88	%	%	NOUN
gs-4428	108	89	94–96	94–96	NUM
gs-4428	108	90	%	%	NOUN
gs-4428	108	91	(	(	PUNCT
gs-4428	108	92	2015–2024	2015–2024	NUM
gs-4428	108	93	range	range	NOUN
gs-4428	108	94	)	)	PUNCT
gs-4428	108	95	who	who	PRON
gs-4428	108	96	/	/	SYM
gs-4428	108	97	unicef	unicef	NOUN
gs-4428	108	98	(	(	PUNCT
gs-4428	108	99	wuenic	wuenic	ADJ
gs-4428	108	100	)	)	PUNCT
gs-4428	108	101	2025	2025	NUM
gs-4428	108	102	above	above	ADP
gs-4428	108	103	who	who	PRON
gs-4428	108	104	90	90	NUM
gs-4428	108	105	%	%	NOUN
gs-4428	108	106	target	target	NOUN
gs-4428	108	107	hepb3	hepb3	NOUN
gs-4428	108	108	coverage	coverage	NOUN
gs-4428	108	109	96	96	NUM
gs-4428	108	110	%	%	NOUN
gs-4428	108	111	94–98	94–98	NUM
gs-4428	108	112	%	%	NOUN
gs-4428	108	113	(	(	PUNCT
gs-4428	108	114	2015–2024	2015–2024	NUM
gs-4428	108	115	range	range	NOUN
gs-4428	108	116	)	)	PUNCT
gs-4428	108	117	who	who	PRON
gs-4428	108	118	/	/	SYM
gs-4428	108	119	unicef	unicef	NOUN
gs-4428	108	120	(	(	PUNCT
gs-4428	108	121	wuenic	wuenic	ADJ
gs-4428	108	122	)	)	PUNCT
gs-4428	108	123	2025	2025	NUM
gs-4428	108	124	sustained	sustain	VERB
gs-4428	108	125	high	high	ADJ
gs-4428	108	126	coverage	coverage	NOUN
gs-4428	108	127	antenatal	antenatal	NOUN
gs-4428	108	128	hbsag	hbsag	NOUN
gs-4428	108	129	screening	screening	NOUN
gs-4428	108	130	pilot	pilot	NOUN
gs-4428	108	131	only	only	ADV
gs-4428	108	132	>	>	SYM
gs-4428	108	133	90	90	NUM
gs-4428	108	134	%	%	NOUN
gs-4428	108	135	of	of	ADP
gs-4428	108	136	facilities	facility	NOUN
gs-4428	108	137	reporting	report	VERB
gs-4428	108	138	ncdc	ncdc	PROPN
gs-4428	108	139	2024	2024	NUM
gs-4428	108	140	national	national	ADJ
gs-4428	108	141	scale	scale	NOUN
gs-4428	108	142	-	-	PUNCT
gs-4428	108	143	up	up	ADP
gs-4428	108	144	testing	testing	NOUN
gs-4428	108	145	–	–	PUNCT
gs-4428	108	146	treatment	treatment	NOUN
gs-4428	108	147	cascade	cascade	NOUN
gs-4428	108	148	estimated	estimate	VERB
gs-4428	108	149	chronic	chronic	ADJ
gs-4428	108	150	hbv	hbv	NOUN
gs-4428	108	151	cases	case	NOUN
gs-4428	108	152	80,000	80,000	NUM
gs-4428	108	153	70,000	70,000	NUM
gs-4428	108	154	tohme	tohme	NOUN
gs-4428	108	155	et	et	PROPN
gs-4428	108	156	al	al	PROPN
gs-4428	108	157	.	.	PROPN
gs-4428	108	158	2024	2024	NUM
gs-4428	108	159	gradual	gradual	ADJ
gs-4428	108	160	decline	decline	NOUN
gs-4428	108	161	diagnosed	diagnose	VERB
gs-4428	108	162	~15	~15	PRON
gs-4428	108	163	%	%	NOUN
gs-4428	108	164	~25	~25	SYM
gs-4428	108	165	%	%	NOUN
gs-4428	108	166	tohme	tohme	NOUN
gs-4428	108	167	et	et	PROPN
gs-4428	108	168	al	al	PROPN
gs-4428	108	169	.	.	PROPN
gs-4428	108	170	2024	2024	NUM
gs-4428	108	171	below	below	ADP
gs-4428	108	172	who	who	PRON
gs-4428	108	173	90	90	NUM
gs-4428	108	174	%	%	NOUN
gs-4428	108	175	target	target	NOUN
gs-4428	108	176	on	on	ADP
gs-4428	108	177	antiviral	antiviral	ADJ
gs-4428	108	178	therapy	therapy	NOUN
gs-4428	108	179	~3	~3	X
gs-4428	108	180	%	%	NOUN
gs-4428	108	181	~5	~5	NOUN
gs-4428	108	182	%	%	NOUN
gs-4428	108	183	cghe	cghe	NOUN
gs-4428	108	184	2025	2025	NUM
gs-4428	108	185	far	far	ADV
gs-4428	108	186	below	below	ADP
gs-4428	108	187	80	80	NUM
gs-4428	108	188	%	%	NOUN
gs-4428	108	189	target	target	NOUN
gs-4428	108	190	equity	equity	NOUN
gs-4428	108	191	/	/	SYM
gs-4428	108	192	systems	system	NOUN
gs-4428	108	193	national	national	ADJ
gs-4428	108	194	treatment	treatment	NOUN
gs-4428	108	195	registry	registry	NOUN
gs-4428	108	196	absent	absent	ADJ
gs-4428	108	197	in	in	ADP
gs-4428	108	198	development	development	NOUN
gs-4428	108	199	cghe	cghe	NOUN
gs-4428	108	200	2025	2025	NUM
gs-4428	108	201	key	key	ADJ
gs-4428	108	202	data	datum	NOUN
gs-4428	108	203	gap	gap	NOUN
gs-4428	108	204	timely	timely	ADV
gs-4428	108	205	birth	birth	NOUN
gs-4428	108	206	dose	dose	NOUN
gs-4428	108	207	(	(	PUNCT
gs-4428	108	208	rural	rural	ADJ
gs-4428	108	209	vs	vs	ADP
gs-4428	108	210	urban	urban	ADJ
gs-4428	108	211	)	)	PUNCT
gs-4428	108	212	–	–	PUNCT
gs-4428	108	213	lower	low	ADJ
gs-4428	108	214	in	in	ADP
gs-4428	108	215	rural	rural	ADJ
gs-4428	108	216	regions	region	NOUN
gs-4428	108	217	ncdc	ncdc	PROPN
gs-4428	108	218	2024	2024	NUM
gs-4428	108	219	equity	equity	NOUN
gs-4428	108	220	challenge	challenge	NOUN
gs-4428	108	221	data	datum	NOUN
gs-4428	108	222	integration	integration	NOUN
gs-4428	108	223	(	(	PUNCT
gs-4428	108	224	hbv	hbv	NOUN
gs-4428	108	225	–	–	PUNCT
gs-4428	108	226	hcv	hcv	PROPN
gs-4428	108	227	–	–	PUNCT
gs-4428	108	228	hiv	hiv	NOUN
gs-4428	108	229	)	)	PUNCT
gs-4428	108	230	partial	partial	NOUN
gs-4428	108	231	not	not	PART
gs-4428	108	232	fully	fully	ADV
gs-4428	108	233	linked	link	VERB
gs-4428	108	234	who	who	PRON
gs-4428	108	235	2024	2024	NUM
gs-4428	108	236	limits	limit	VERB
gs-4428	108	237	surveillance	surveillance	NOUN
gs-4428	108	238	note	note	NOUN
gs-4428	108	239	.	.	PUNCT
gs-4428	109	1	hbsag	hbsag	NOUN
gs-4428	109	2	=	=	PUNCT
gs-4428	109	3	hepatitis	hepatitis	PROPN
gs-4428	109	4	b	b	PROPN
gs-4428	109	5	surface	surface	NOUN
gs-4428	109	6	antigen	antigen	ADV
gs-4428	109	7	;	;	PUNCT
gs-4428	109	8	hepb	hepb	PROPN
gs-4428	109	9	-	-	PUNCT
gs-4428	109	10	bd	bd	PROPN
gs-4428	109	11	=	=	NOUN
gs-4428	109	12	birth	birth	NOUN
gs-4428	109	13	dose	dose	NOUN
gs-4428	109	14	;	;	PUNCT
gs-4428	109	15	hepb3	hepb3	NOUN
gs-4428	109	16	=	=	SYM
gs-4428	109	17	three	three	NUM
gs-4428	109	18	-	-	PUNCT
gs-4428	109	19	dose	dose	NOUN
gs-4428	109	20	series	series	NOUN
gs-4428	109	21	;	;	PUNCT
gs-4428	109	22	pmtct	pmtct	NOUN
gs-4428	109	23	=	=	SYM
gs-4428	109	24	prevention	prevention	NOUN
gs-4428	109	25	of	of	ADP
gs-4428	109	26	mother	mother	NOUN
gs-4428	109	27	-	-	PUNCT
gs-4428	109	28	to	to	ADP
gs-4428	109	29	-	-	PUNCT
gs-4428	109	30	child	child	NOUN
gs-4428	109	31	transmission	transmission	NOUN
gs-4428	109	32	;	;	PUNCT
gs-4428	109	33	cghe	cghe	NOUN
gs-4428	109	34	=	=	SYM
gs-4428	109	35	coalition	coalition	NOUN
gs-4428	109	36	for	for	ADP
gs-4428	109	37	global	global	ADJ
gs-4428	109	38	hepatitis	hepatitis	NOUN
gs-4428	109	39	elimination	elimination	NOUN
gs-4428	109	40	;	;	PUNCT
gs-4428	109	41	wuenic	wuenic	NOUN
gs-4428	109	42	=	=	SYM
gs-4428	109	43	who	who	PRON
gs-4428	109	44	/	/	SYM
gs-4428	109	45	unicef	unicef	NOUN
gs-4428	109	46	estimates	estimate	NOUN
gs-4428	109	47	of	of	ADP
gs-4428	109	48	national	national	ADJ
gs-4428	109	49	immunization	immunization	NOUN
gs-4428	109	50	coverage	coverage	NOUN
gs-4428	109	51	.	.	PUNCT
gs-4428	110	1	ranges	range	NOUN
gs-4428	110	2	reflect	reflect	VERB
gs-4428	110	3	annual	annual	ADJ
gs-4428	110	4	coverage	coverage	NOUN
gs-4428	110	5	across	across	ADP
gs-4428	110	6	2015–2024	2015–2024	NUM
gs-4428	110	7	;	;	PUNCT
gs-4428	110	8	insert	insert	VERB
gs-4428	110	9	the	the	DET
gs-4428	110	10	exact	exact	ADJ
gs-4428	110	11	latest	late	ADJ
gs-4428	110	12	year	year	NOUN
gs-4428	110	13	’s	’s	PART
gs-4428	110	14	value	value	NOUN
gs-4428	110	15	if	if	SCONJ
gs-4428	110	16	the	the	DET
gs-4428	110	17	journal	journal	NOUN
gs-4428	110	18	prefers	prefer	VERB
gs-4428	110	19	a	a	DET
gs-4428	110	20	single	single	ADJ
gs-4428	110	21	point	point	NOUN
gs-4428	110	22	estimate	estimate	NOUN
gs-4428	110	23	.	.	PUNCT
gs-4428	111	1	“	"	PUNCT
gs-4428	111	2	timely	timely	ADJ
gs-4428	111	3	”	"	PUNCT
gs-4428	111	4	=	=	SYM
gs-4428	111	5	birth	birth	NOUN
gs-4428	111	6	dose	dose	NOUN
gs-4428	111	7	administered	administer	VERB
gs-4428	111	8	within	within	ADP
gs-4428	111	9	24	24	NUM
gs-4428	111	10	hours	hour	NOUN
gs-4428	111	11	of	of	ADP
gs-4428	111	12	birth	birth	NOUN
gs-4428	111	13	.	.	PUNCT
gs-4428	112	1	abbreviations	abbreviation	NOUN
gs-4428	112	2	anti	anti	ADJ
gs-4428	112	3	-	-	NOUN
gs-4428	112	4	hbc	hbc	ADJ
gs-4428	112	5	—	—	PUNCT
gs-4428	112	6	total	total	ADJ
gs-4428	112	7	hepatitis	hepatitis	PROPN
gs-4428	112	8	b	b	PROPN
gs-4428	112	9	core	core	NOUN
gs-4428	112	10	antibody	antibody	NOUN
gs-4428	112	11	ghss	ghss	PROPN
gs-4428	112	12	—	—	PUNCT
gs-4428	112	13	global	global	ADJ
gs-4428	112	14	health	health	NOUN
gs-4428	112	15	sector	sector	NOUN
gs-4428	112	16	strategies	strategy	NOUN
gs-4428	112	17	hbig	hbig	ADJ
gs-4428	112	18	—	—	PUNCT
gs-4428	112	19	hepatitis	hepatitis	NOUN
gs-4428	112	20	b	b	PROPN
gs-4428	112	21	immune	immune	ADJ
gs-4428	112	22	globulin	globulin	NOUN
gs-4428	112	23	hbsag	hbsag	NOUN
gs-4428	112	24	—	—	PUNCT
gs-4428	112	25	hepatitis	hepatitis	PROPN
gs-4428	112	26	b	b	PROPN
gs-4428	112	27	surface	surface	NOUN
gs-4428	112	28	antigen	antigen	NOUN
gs-4428	112	29	hbv	hbv	NOUN
gs-4428	112	30	—	—	PUNCT
gs-4428	112	31	hepatitis	hepatitis	PROPN
gs-4428	112	32	b	b	PROPN
gs-4428	112	33	virus	virus	NOUN
gs-4428	112	34	hcv	hcv	NOUN
gs-4428	112	35	—	—	PUNCT
gs-4428	112	36	hepatitis	hepatitis	PROPN
gs-4428	112	37	c	c	PROPN
gs-4428	112	38	virus	virus	PROPN
gs-4428	112	39	hiv	hiv	PROPN
gs-4428	112	40	—	—	PUNCT
gs-4428	112	41	human	human	ADJ
gs-4428	112	42	immunodeficiency	immunodeficiency	NOUN
gs-4428	112	43	virus	virus	NOUN
gs-4428	112	44	ncdc	ncdc	ADJ
gs-4428	112	45	—	—	PUNCT
gs-4428	112	46	national	national	ADJ
gs-4428	112	47	center	center	NOUN
gs-4428	112	48	for	for	ADP
gs-4428	112	49	disease	disease	NOUN
gs-4428	112	50	control	control	NOUN
gs-4428	112	51	and	and	CCONJ
gs-4428	112	52	public	public	ADJ
gs-4428	112	53	health	health	NOUN
gs-4428	112	54	mmwr	mmwr	NOUN
gs-4428	112	55	—	—	PUNCT
gs-4428	112	56	morbidity	morbidity	NOUN
gs-4428	112	57	and	and	CCONJ
gs-4428	112	58	mortality	mortality	NOUN
gs-4428	112	59	weekly	weekly	ADJ
gs-4428	112	60	report	report	NOUN
gs-4428	112	61	pmtct	pmtct	NOUN
gs-4428	112	62	—	—	PUNCT
gs-4428	112	63	prevention	prevention	NOUN
gs-4428	112	64	of	of	ADP
gs-4428	112	65	mother	mother	NOUN
gs-4428	112	66	-	-	PUNCT
gs-4428	112	67	to	to	ADP
gs-4428	112	68	-	-	PUNCT
gs-4428	112	69	child	child	NOUN
gs-4428	112	70	transmission	transmission	NOUN
gs-4428	112	71	who	who	PRON
gs-4428	112	72	—	—	PUNCT
gs-4428	112	73	world	world	PROPN
gs-4428	112	74	health	health	NOUN
gs-4428	112	75	organization	organization	NOUN
gs-4428	112	76	georgian	georgian	NOUN
gs-4428	112	77	scientists/	scientists/	NUM
gs-4428	112	78	.	.	PUNCT
gs-4428	113	1	7	7	NUM
gs-4428	113	2	n	n	DET
gs-4428	113	3	4	4	NUM
gs-4428	113	4	,	,	PUNCT
gs-4428	113	5	2025	2025	NUM
gs-4428	113	6	629	629	NUM
gs-4428	113	7	wuenic	wuenic	NOUN
gs-4428	113	8	—	—	PUNCT
gs-4428	113	9	who	who	PRON
gs-4428	113	10	–	–	PUNCT
gs-4428	113	11	unicef	unicef	PROPN
gs-4428	113	12	national	national	ADJ
gs-4428	113	13	immunization	immunization	NOUN
gs-4428	113	14	coverage	coverage	NOUN
gs-4428	113	15	references	reference	NOUN
gs-4428	113	16	arksey	arksey	PROPN
gs-4428	113	17	h	h	NOUN
gs-4428	113	18	,	,	PUNCT
gs-4428	113	19	o’malley	o’malley	PROPN
gs-4428	113	20	l	l	NOUN
gs-4428	113	21	(	(	PUNCT
gs-4428	113	22	2005	2005	NUM
gs-4428	113	23	)	)	PUNCT
gs-4428	114	1	scoping	scope	VERB
gs-4428	114	2	studies	study	NOUN
gs-4428	114	3	:	:	PUNCT
gs-4428	114	4	towards	towards	ADP
gs-4428	114	5	a	a	DET
gs-4428	114	6	methodological	methodological	ADJ
gs-4428	114	7	framework	framework	NOUN
gs-4428	114	8	.	.	PUNCT
gs-4428	115	1	int	int	NOUN
gs-4428	115	2	j	j	PROPN
gs-4428	115	3	soc	soc	NOUN
gs-4428	115	4	res	re	VERB
gs-4428	115	5	methodol	methodol	NOUN
gs-4428	115	6	8(1	8(1	NOUN
gs-4428	115	7	):	):	PUNCT
gs-4428	115	8	19–32	19–32	NUM
gs-4428	115	9	.	.	PUNCT
gs-4428	116	1	https://doi.org/10.1080/1364557032000119616	https://doi.org/10.1080/1364557032000119616	PROPN
gs-4428	116	2	coalition	coalition	NOUN
gs-4428	116	3	for	for	ADP
gs-4428	116	4	global	global	ADJ
gs-4428	116	5	hepatitis	hepatitis	NOUN
gs-4428	116	6	elimination	elimination	NOUN
gs-4428	116	7	(	(	PUNCT
gs-4428	116	8	2025	2025	NUM
gs-4428	116	9	)	)	PUNCT
gs-4428	116	10	georgia	georgia	PROPN
gs-4428	116	11	:	:	PUNCT
gs-4428	116	12	national	national	ADJ
gs-4428	116	13	hepatitis	hepatitis	PROPN
gs-4428	116	14	elimination	elimination	NOUN
gs-4428	116	15	profile	profile	NOUN
gs-4428	116	16	.	.	PUNCT
gs-4428	117	1	cghe	cghe	PROPN
gs-4428	117	2	,	,	PUNCT
gs-4428	117	3	atlanta	atlanta	PROPN
gs-4428	117	4	.	.	PUNCT
gs-4428	118	1	https://www.globalhep.org/countries/georgia	https://www.globalhep.org/countries/georgia	PROPN
gs-4428	118	2	khetsuriani	khetsuriani	PROPN
gs-4428	118	3	n	n	CCONJ
gs-4428	118	4	,	,	PUNCT
gs-4428	118	5	gamkrelidze	gamkrelidze	NOUN
gs-4428	118	6	a	a	DET
gs-4428	118	7	,	,	PUNCT
gs-4428	118	8	shadaker	shadaker	NOUN
gs-4428	118	9	s	s	PROPN
gs-4428	118	10	,	,	PUNCT
gs-4428	118	11	et	et	PROPN
gs-4428	118	12	al	al	PROPN
gs-4428	118	13	.	.	PROPN
gs-4428	119	1	(	(	PUNCT
gs-4428	119	2	2023	2023	NUM
gs-4428	119	3	)	)	PUNCT
gs-4428	119	4	toward	toward	ADP
gs-4428	119	5	reaching	reach	VERB
gs-4428	119	6	hepatitis	hepatitis	NOUN
gs-4428	119	7	b	b	PROPN
gs-4428	119	8	goals	goal	NOUN
gs-4428	119	9	:	:	PUNCT
gs-4428	119	10	hepatitis	hepatitis	PROPN
gs-4428	119	11	b	b	PROPN
gs-4428	119	12	epidemiology	epidemiology	NOUN
gs-4428	119	13	and	and	CCONJ
gs-4428	119	14	the	the	DET
gs-4428	119	15	impact	impact	NOUN
gs-4428	119	16	of	of	ADP
gs-4428	119	17	two	two	NUM
gs-4428	119	18	decades	decade	NOUN
gs-4428	119	19	of	of	ADP
gs-4428	119	20	vaccination	vaccination	NOUN
gs-4428	119	21	,	,	PUNCT
gs-4428	119	22	georgia	georgia	PROPN
gs-4428	119	23	,	,	PUNCT
gs-4428	119	24	2021	2021	NUM
gs-4428	119	25	.	.	PUNCT
gs-4428	120	1	euro	euro	NOUN
gs-4428	120	2	surveill	surveill	NOUN
gs-4428	120	3	28(30	28(30	NUM
gs-4428	120	4	):	):	PUNCT
gs-4428	120	5	2200837	2200837	NUM
gs-4428	120	6	.	.	PUNCT
gs-4428	121	1	https://doi.org/10.2807/1560-7917.es.2023.28.30.2200837	https://doi.org/10.2807/1560-7917.es.2023.28.30.2200837	PROPN
gs-4428	121	2	kasradze	kasradze	VERB
gs-4428	121	3	a	a	DET
gs-4428	121	4	,	,	PUNCT
gs-4428	121	5	shadaker	shadaker	PROPN
gs-4428	121	6	s	s	PROPN
gs-4428	121	7	,	,	PUNCT
gs-4428	121	8	kuchuloria	kuchuloria	PROPN
gs-4428	121	9	t	t	PROPN
gs-4428	121	10	,	,	PUNCT
gs-4428	121	11	et	et	PROPN
gs-4428	121	12	al	al	PROPN
gs-4428	121	13	.	.	PROPN
gs-4428	122	1	(	(	PUNCT
gs-4428	122	2	2020	2020	NUM
gs-4428	122	3	)	)	PUNCT
gs-4428	122	4	the	the	DET
gs-4428	122	5	burden	burden	NOUN
gs-4428	122	6	and	and	CCONJ
gs-4428	122	7	epidemiology	epidemiology	NOUN
gs-4428	122	8	of	of	ADP
gs-4428	122	9	hepatitis	hepatitis	PROPN
gs-4428	122	10	b	b	PROPN
gs-4428	122	11	and	and	CCONJ
gs-4428	122	12	hepatitis	hepatitis	PROPN
gs-4428	122	13	d	d	PROPN
gs-4428	122	14	in	in	ADP
gs-4428	122	15	georgia	georgia	PROPN
gs-4428	122	16	:	:	PUNCT
gs-4428	122	17	findings	finding	NOUN
gs-4428	122	18	from	from	ADP
gs-4428	122	19	the	the	DET
gs-4428	122	20	national	national	ADJ
gs-4428	122	21	seroprevalence	seroprevalence	NOUN
gs-4428	122	22	survey	survey	NOUN
gs-4428	122	23	.	.	PUNCT
gs-4428	123	1	public	public	ADJ
gs-4428	123	2	health	health	PROPN
gs-4428	123	3	185:341–347	185:341–347	NUM
gs-4428	123	4	.	.	PUNCT
gs-4428	124	1	https://doi.org/10.1016/j.puhe.2020.06.024national	https://doi.org/10.1016/j.puhe.2020.06.024national	ADJ
gs-4428	124	2	center	center	NOUN
gs-4428	124	3	for	for	ADP
gs-4428	124	4	disease	disease	NOUN
gs-4428	124	5	control	control	NOUN
gs-4428	124	6	and	and	CCONJ
gs-4428	124	7	public	public	ADJ
gs-4428	124	8	health	health	NOUN
gs-4428	124	9	(	(	PUNCT
gs-4428	124	10	ncdc	ncdc	NOUN
gs-4428	124	11	)	)	PUNCT
gs-4428	124	12	(	(	PUNCT
gs-4428	124	13	2024	2024	NUM
gs-4428	124	14	)	)	PUNCT
gs-4428	124	15	annual	annual	ADJ
gs-4428	124	16	report	report	NOUN
gs-4428	124	17	on	on	ADP
gs-4428	124	18	immunization	immunization	NOUN
gs-4428	124	19	and	and	CCONJ
gs-4428	124	20	pmtct	pmtct	NOUN
gs-4428	124	21	activities	activity	NOUN
gs-4428	124	22	in	in	ADP
gs-4428	124	23	georgia	georgia	PROPN
gs-4428	124	24	,	,	PUNCT
gs-4428	124	25	2024	2024	NUM
gs-4428	124	26	.	.	PUNCT
gs-4428	125	1	tbilisi	tbilisi	PROPN
gs-4428	125	2	:	:	PUNCT
gs-4428	126	1	ncdc	ncdc	ADJ
gs-4428	126	2	.	.	PUNCT
gs-4428	127	1	polaris	polaris	PROPN
gs-4428	127	2	observatory	observatory	ADJ
gs-4428	127	3	collaborators	collaborator	NOUN
gs-4428	127	4	(	(	PUNCT
gs-4428	127	5	2023	2023	NUM
gs-4428	127	6	)	)	PUNCT
gs-4428	127	7	global	global	ADJ
gs-4428	127	8	prevalence	prevalence	NOUN
gs-4428	127	9	,	,	PUNCT
gs-4428	127	10	treatment	treatment	NOUN
gs-4428	127	11	,	,	PUNCT
gs-4428	127	12	and	and	CCONJ
gs-4428	127	13	prevention	prevention	NOUN
gs-4428	127	14	of	of	ADP
gs-4428	127	15	hepatitis	hepatitis	PROPN
gs-4428	127	16	b	b	PROPN
gs-4428	127	17	virus	virus	NOUN
gs-4428	127	18	infection	infection	NOUN
gs-4428	127	19	in	in	ADP
gs-4428	127	20	2022	2022	NUM
gs-4428	127	21	.	.	PUNCT
gs-4428	128	1	lancet	lancet	PROPN
gs-4428	128	2	gastroenterol	gastroenterol	PROPN
gs-4428	128	3	hepatol	hepatol	ADJ
gs-4428	128	4	8(5	8(5	NUM
gs-4428	128	5	):	):	PUNCT
gs-4428	128	6	393–406	393–406	NUM
gs-4428	128	7	.	.	PUNCT
gs-4428	129	1	https://doi.org/10.1016/s2468-1253(23)00026-0	https://doi.org/10.1016/s2468-1253(23)00026-0	VERB
gs-4428	129	2	tohme	tohme	PROPN
gs-4428	129	3	ra	ra	PROPN
gs-4428	129	4	,	,	PUNCT
gs-4428	129	5	shadaker	shadaker	PROPN
gs-4428	129	6	s	s	PART
gs-4428	129	7	,	,	PUNCT
gs-4428	129	8	adamia	adamia	NOUN
gs-4428	129	9	e	e	NOUN
gs-4428	129	10	,	,	PUNCT
gs-4428	129	11	et	et	PROPN
gs-4428	129	12	al	al	PROPN
gs-4428	129	13	.	.	PROPN
gs-4428	130	1	(	(	PUNCT
gs-4428	130	2	2024	2024	NUM
gs-4428	130	3	)	)	PUNCT
gs-4428	130	4	progress	progress	NOUN
gs-4428	130	5	toward	toward	ADP
gs-4428	130	6	the	the	DET
gs-4428	130	7	elimination	elimination	NOUN
gs-4428	130	8	of	of	ADP
gs-4428	130	9	hepatitis	hepatitis	PROPN
gs-4428	130	10	b	b	PROPN
gs-4428	130	11	and	and	CCONJ
gs-4428	130	12	hepatitis	hepatitis	PROPN
gs-4428	130	13	c	c	PROPN
gs-4428	130	14	in	in	ADP
gs-4428	130	15	the	the	DET
gs-4428	130	16	country	country	NOUN
gs-4428	130	17	of	of	ADP
gs-4428	130	18	georgia	georgia	PROPN
gs-4428	130	19	,	,	PUNCT
gs-4428	130	20	april	april	PROPN
gs-4428	130	21	2015	2015	NUM
gs-4428	130	22	–	–	PUNCT
gs-4428	130	23	april	april	PROPN
gs-4428	130	24	2024	2024	NUM
gs-4428	130	25	.	.	PUNCT
gs-4428	131	1	mmwr	mmwr	ADJ
gs-4428	131	2	morb	morb	NOUN
gs-4428	131	3	mortal	mortal	ADJ
gs-4428	131	4	wkly	wkly	ADJ
gs-4428	131	5	rep	rep	PROPN
gs-4428	131	6	73(30):660–666	73(30):660–666	PROPN
gs-4428	131	7	.	.	PUNCT
gs-4428	132	1	https://doi.org/10.15585/mmwr.mm7330a1	https://doi.org/10.15585/mmwr.mm7330a1	PROPN
gs-4428	132	2	tricco	tricco	PROPN
gs-4428	132	3	ac	ac	PROPN
gs-4428	132	4	,	,	PUNCT
gs-4428	132	5	lillie	lillie	PROPN
gs-4428	132	6	e	e	PROPN
gs-4428	132	7	,	,	PUNCT
gs-4428	132	8	zarin	zarin	PROPN
gs-4428	132	9	w	w	PROPN
gs-4428	132	10	,	,	PUNCT
gs-4428	132	11	et	et	PROPN
gs-4428	132	12	al	al	PROPN
gs-4428	132	13	.	.	PUNCT
gs-4428	133	1	(	(	PUNCT
gs-4428	133	2	2018	2018	NUM
gs-4428	133	3	)	)	PUNCT
gs-4428	133	4	prisma	prisma	NOUN
gs-4428	133	5	extension	extension	NOUN
gs-4428	133	6	for	for	ADP
gs-4428	133	7	scoping	scope	VERB
gs-4428	133	8	reviews	review	NOUN
gs-4428	133	9	(	(	PUNCT
gs-4428	133	10	prismascr	prismascr	NOUN
gs-4428	133	11	):	):	PUNCT
gs-4428	133	12	checklist	checklist	NOUN
gs-4428	133	13	and	and	CCONJ
gs-4428	133	14	explanation	explanation	NOUN
gs-4428	133	15	.	.	PUNCT
gs-4428	134	1	ann	ann	PROPN
gs-4428	134	2	intern	intern	PROPN
gs-4428	134	3	med	me	VERB
gs-4428	134	4	169(7	169(7	NUM
gs-4428	134	5	):	):	PUNCT
gs-4428	134	6	467–473	467–473	NUM
gs-4428	134	7	.	.	PUNCT
gs-4428	135	1	https://doi.org/10.7326/m18-0850	https://doi.org/10.7326/m18-0850	ADP
gs-4428	135	2	world	world	NOUN
gs-4428	135	3	health	health	NOUN
gs-4428	135	4	organization	organization	NOUN
gs-4428	135	5	(	(	PUNCT
gs-4428	135	6	2022a	2022a	NUM
gs-4428	135	7	)	)	PUNCT
gs-4428	135	8	global	global	ADJ
gs-4428	135	9	health	health	NOUN
gs-4428	135	10	sector	sector	NOUN
gs-4428	135	11	strategies	strategy	NOUN
gs-4428	135	12	on	on	ADP
gs-4428	135	13	hiv	hiv	PROPN
gs-4428	135	14	,	,	PUNCT
gs-4428	135	15	viral	viral	ADJ
gs-4428	135	16	hepatitis	hepatitis	NOUN
gs-4428	135	17	and	and	CCONJ
gs-4428	135	18	sexually	sexually	ADV
gs-4428	135	19	transmitted	transmit	VERB
gs-4428	135	20	infections	infection	NOUN
gs-4428	135	21	2022–2030	2022–2030	NUM
gs-4428	135	22	.	.	PUNCT
gs-4428	136	1	who	who	PRON
gs-4428	136	2	,	,	PUNCT
gs-4428	136	3	geneva	geneva	PROPN
gs-4428	136	4	.	.	PUNCT
gs-4428	136	5	https://www.who.int/publications/i/item/9789240053779	https://www.who.int/publications/i/item/9789240053779	PROPN
gs-4428	136	6	world	world	PROPN
gs-4428	136	7	health	health	PROPN
gs-4428	136	8	organization	organization	NOUN
gs-4428	136	9	(	(	PUNCT
gs-4428	136	10	2022b	2022b	NUM
gs-4428	136	11	)	)	PUNCT
gs-4428	136	12	global	global	ADJ
gs-4428	136	13	health	health	NOUN
gs-4428	136	14	sector	sector	NOUN
gs-4428	136	15	strategies	strategy	NOUN
gs-4428	136	16	2022–2030	2022–2030	NUM
gs-4428	136	17	:	:	PUNCT
gs-4428	136	18	overview	overview	NOUN
gs-4428	136	19	page	page	NOUN
gs-4428	136	20	.	.	PUNCT
gs-4428	137	1	who	who	PRON
gs-4428	137	2	,	,	PUNCT
gs-4428	137	3	geneva	geneva	PROPN
gs-4428	137	4	.	.	PUNCT
gs-4428	138	1	https://www.who.int/teams/global-hiv-hepatitis-and-stisprogrammes/strategies/global-health-sector-strategies	https://www.who.int/teams/global-hiv-hepatitis-and-stisprogrammes/strategies/global-health-sector-strategie	NOUN
gs-4428	138	2	world	world	PROPN
gs-4428	138	3	health	health	PROPN
gs-4428	138	4	organization	organization	NOUN
gs-4428	138	5	(	(	PUNCT
gs-4428	138	6	2024	2024	NUM
gs-4428	138	7	)	)	PUNCT
gs-4428	138	8	regional	regional	ADJ
gs-4428	138	9	hepatitis	hepatitis	NOUN
gs-4428	138	10	elimination	elimination	NOUN
gs-4428	138	11	progress	progress	NOUN
gs-4428	138	12	report	report	NOUN
gs-4428	138	13	—	—	PUNCT
gs-4428	138	14	who	who	PRON
gs-4428	138	15	european	european	ADJ
gs-4428	138	16	region	region	PROPN
gs-4428	138	17	2024	2024	NUM
gs-4428	138	18	.	.	PUNCT
gs-4428	139	1	who	who	PRON
gs-4428	139	2	,	,	PUNCT
gs-4428	139	3	copenhagen	copenhagen	PROPN
gs-4428	139	4	.	.	PUNCT
gs-4428	140	1	who	who	PRON
gs-4428	140	2	/	/	SYM
gs-4428	140	3	unicef	unicef	PROPN
gs-4428	140	4	(	(	PUNCT
gs-4428	140	5	2025	2025	NUM
gs-4428	140	6	)	)	PUNCT
gs-4428	140	7	estimates	estimate	NOUN
gs-4428	140	8	of	of	ADP
gs-4428	140	9	national	national	ADJ
gs-4428	140	10	immunization	immunization	NOUN
gs-4428	140	11	coverage	coverage	NOUN
gs-4428	140	12	(	(	PUNCT
gs-4428	140	13	wuenic	wuenic	NOUN
gs-4428	140	14	):	):	PUNCT
gs-4428	140	15	georgia	georgia	PROPN
gs-4428	140	16	,	,	PUNCT
gs-4428	140	17	2025	2025	NUM
gs-4428	140	18	update	update	NOUN
gs-4428	140	19	.	.	PUNCT
gs-4428	141	1	who	who	PRON
gs-4428	141	2	/	/	SYM
gs-4428	141	3	unicef	unicef	PROPN
gs-4428	141	4	,	,	PUNCT
gs-4428	141	5	geneva	geneva	PROPN
gs-4428	141	6	.	.	PUNCT
gs-4428	142	1	https://immunizationdata.who.int	https://immunizationdata.who.int	PROPN